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The aged T cell is characterized by decreased responsiveness to stimulation. Aging is 
associated with reduced membrane glycerophospholipid (GPL) to cholesterol ratios so it 
is interesting that deletion of mitochondrial glycerol-3-phosphate acyltransferase-1 which 
catalyzes the first step in de novo GPL synthesis induces an aged T cell phenotype in 
otherwise healthy mice.  GPAT-1 could regulate T cell function through three possible 
mechanisms:  maintenance of membrane GPL ratios and membrane based signaling, 
providing a specific substrate for downstream signaling, or direct regulation of cellular 
metabolism. Therefore, the goal of this project was to determine whether these 
mechanisms contribute to the dysfunctional T cell phenotype observed with decreased 
GPAT-1 activity. T cell stimulation requires significant upregulation of metabolic 
processes to drive clonal expansion and cytokine production. T cell dysfunction in 
GPAT-1 knockout mice may be partially explained by altered metabolic function. We 
found that GPAT-1 KO T cells have significantly reduced basal respiration rates and 
spare respiratory capacity which is not compensated for by increased glycolytic 
metabolism suggesting an inherent metabolic defect in GPAT-1 KO T cells. To better 
understand mechanistically how GPAT-1 regulates T cell function we moved into the 
Jurkat T cell line and found that shRNA mediated knockdown of the human isoform of 
 viii 
GPAT-1 (GPAM) recapitulated key aspects of the dysfunctional T cell phenotype we 
observed in the mouse including highly significant reductions in IL-2 production and 
altered membrane GPL to cholesterol ratios. Phosphatidic acid addition was not capable 
of rescuing these deficiencies suggesting that GPAT-1/GPAM activity is required for 
proper T cell function. This was the first time that GPAT-1 activity has been shown to be 
important for T cell function in a non-murine model system and strongly suggests that 
GPAT-1/GPAM deficiency regulates T cell function at the cellular level. We further 
demonstrate that phosphorylation of ZAP-70 a proximal effector of T cell activation is 
significantly reduced in GPAM knock down Jurkat T cells, suggesting that membrane 
based signaling is dysfunctional. Taken together these data suggest that GPAT-1 is 
necessary for regulating cellular energy demands in T cells and essential for optimal T 
cell activation following stimulation.  
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Chapter 1 
Review of Literature 
 
1.1 Overview 
A key role is emerging for cellular metabolism in the regulation of T cell survival, 
differentiation, memory, and effector function  
1
,
2
,
3
,
4
,
5
. The classical paradigm of T cell 
activation revolves around an activation induced metabolic switch that enables the stimulated 
cell to preferentially engage aerobic glycolytic metabolic pathways to meet energy needs in a 
process similar to the Warburg effect observed in cancer cells 
1
,
6
. Current studies are starting to 
reveal that this paradigm is only part of the story and the resting energy state of the cell and 
factors of the metabolic machinery itself play an important role in determining T cell fate and 
effector function. Within the current paradigm, the role of lipid metabolism is largely 
understudied but recent developments are beginning to show that an important determining 
factor of T cell subset differentiation and effector function is the extent to which lipid or 
glycolytic pathways are engaged in the T cell 
3
,
5
,
4
,
2
.  
New studies are revealing a pivotal role for lipid metabolism in T cell fate and effector 
function. It is very interesting then, that ablation of one of the rate limiting enzymes of de novo 
triacylglyceride (TAG) and gycerophospholipid (GPL) synthesis, GPAT-1, appears to play a 
central role in T cell biology. Specifically, T cells isolated from Gpat-1
 -/-
 mice are deficient in 
proliferation and interleukin-2 (IL-2) production while mice lacking GPAT-1  are more 
susceptible to virulence associated with Coxsackievirus B3 infection as demonstrated by higher 
incidences of mortality and  100 fold increases of viral titer in the heart 
7
,
8
. These dysfunctions 
 2 
and pathologies are of physiological relevance as they mirror defects observed in the aging 
immune system. Gpat-1 
-/- 
mice are deficient in nearly all major classes of membrane 
glycerophospholipid 
7
. We hypothesize that these deficiencies in GPL result in changes to 
membrane fluid dynamics similar to those observed with aging.  It is also of interest that GPAT-
1 activity is significantly down regulated in T cells isolated from old rats, implying that down 
regulation of GPAT-1 with age may be a major contributor to altered membrane composition 
coincident with aging 
9
. These data suggest that GPAT-1 may play a key role in the decline of 
the adaptive immune response with aging. Engagement of membrane based receptors such as the 
T cell receptor (TCR) initiate internal signal transduction cascades necessary for T cell 
activation. The Membrane Gate Theory  postulates that age related changes in membrane 
structure perturb engagement of membrane based receptors which results in an insensitivity to 
antigenic stimuli and subsequent deficiencies in receptor tyrosine kinase and G protein coupled 
receptor signaling
10
.  It is therefore possible that GPAT-1 regulates T cell function through 
modulation of membrane phospholipid composition and membrane based receptor signaling. 
Additionally, dysregulation of lipid metabolic pathways have specifically been shown to enhance 
T cell phenotypes that may work against an effective T cell driven immune response. It has been 
demonstrated that encouraging lipid oxidation over glycolysis can increase the expression of 
FOXP3, a transcription factor essential for the function and development of regulatory T cells 
(Tregs) which act to suppress effector T cell function 
4
. Expression of this transcription factor in 
Jurkat T cells has been shown to be sufficient to induce a Treg-like phenotype 
11
. Furthermore, 
studies in elderly humans have revealed a significant increase in FOXP3+ T cells and shown that 
in vitro depletion of this population improves effector T cell function
12
. We have also observed 
that FOXP3+ T cells are elevated in the Gpat-1
 -/-
 mouse (unpublished observation, Faris, Jolly).  
 3 
Findings that increased lipid oxidation can alter T cell subsets is significant as it has been 
suggested that in the absence of GPAT-1 lipid oxidation is elevated. This is thought to be the 
result of fatty acyl-CoA being shunted away from TAG and GPL synthesis in the absence of 
GPAT-1 and toward mitochondrial β-oxidation via carnitine palmitoyl transferase 1 (CPT-1a). 
CPT-1a is located on the mitochondrial membrane and is believed to compete with GPAT-1for 
fatty acyl-CoA substrate. Interestingly, we have recently shown that CPT-1a expression is 
elevated in thymic T cells from  Gpat-1 
-/- 
mice 
13
.  
Our work in the Gpat-1
 -/-
 mouse has helped us to develop a model in which to observe 
the effects of altered membrane lipid composition on T cell function. To date this is the only 
known model of reduced cellular glycerophospholipid. However, a question that often arises in 
the study of a specific cell type isolated from a whole animal knockout is to what extent the 
macro environment of the model influences the observed cellular phenotype. Therefore, one goal 
of this project is to determine whether the dysfunctional T cell phenotype we observe in murine 
Gpat-1
 -/- 
 T cells is due to an inherent loss of GPAT-1 resulting in a cell intrinsic defect rather 
than being the consequence of altered thymic development, epigenetic changes, or other 
mechanisms in the periphery of the Gpat 
-/- 
mouse. To accomplish this goal we generated a 
Jurkat T cell with GPAM, the human homologue of GPAT-1, knock down line (GPAMKD). 
This cell line will be used to determine whether the phenotype of GPAT-1 deficient T cells is 
due to developmental processes or a cell intrinsic effect. This will also be the first time that the 
effects of GPAM deletion are observed in a human T cell line. Furthermore, this line will be used 
to better our understanding of how GPAT-1/GPAM mechanistically regulates T cell function and 
fate.  
 4 
It has long been speculated that GPAT-1 deficiency results in elevated lipid oxidation. 
Previous studies revealed a significant increase in radical oxygen species (ROS) from 
hepatocytes of Gpat-1
 -/-
 mice which was suggested to be a result of increased fatty acid 
metabolism
14
. However, to date, direct metabolic analysis of Gpat-1
 -/-
 cells has not been 
conducted. It is possible to determine the precise contributions of respiratory and glycolytic 
metabolism by measuring the oxygen consumption rate (OCR) and extra cellular acidification 
rate (ECAR) using special instrumentation such as the Seahorse XF analyzer. Therefore, the 
second major goal of this project is to determine whether primary murine T cells from Gpat-1
 -/-
 
mice exhibit altered metabolic profiles at rest and in the presence of various modes of 
stimulation. This information combined with our previous observations will help us to gain 
insight as to whether GPAT-1 plays a role in regulating the metabolic switch in T cells and if so, 
how T cell effector function is modulated by these processes. 
The overall goal of this project is to gain mechanistic insight as to how GPAT-1/GPAM 
regulates T cell fate and function. Understanding how GPAT-1 regulates T cell function will 
better our understanding of how metabolism influences T cell fate and effector function. 
 
 
 
 
 
 
 5 
1.2 Objectives 
The objectives of this project are to: 
 
1) Develop and phenotypically characterize a stable GPAM knockdown Jurkat T cell line to 
determine whether GPAT-1/GPAM deficient phenotypes are the result of a cell intrinsic 
mechanism 
Hypothesis: GPAT-1/GPAM deficiency results in cell intrinsic defects in the absence of 
developmental processes and GPAMKD Jurkat T cells recapitulate key aspects of T cell 
dysfunction observed in GPAT-1 knockout mice. 
2) Identify the mechanism(s) by which GPAT-1/GPAM regulates T cell function and fate 
Hypothesis: GPAT-1/GPAM regulates T cell function and fate through either, or a combination 
of a) Altering T cell metabolism, b) modulation of membrane phospholipids and membrane 
based receptor signaling, c) regulation of PA dependent signaling 
 
 
 
 
 
 
 6 
1.3 Background 
GPAT-1 is an 828 amino acid multi-pass integral outer mitochondrial membrane protein 
that catalyzes the conversion of glycerol-3 phosphate and acyl-CoA to lyosphosphatidic acid 
(LPA) which is then further acylated to produce phosphatidic acid (PA) presumably for 
phospholipid and triglyceride synthesis (reviewed by Coleman in 
15
). Fatty acids are activated to 
acyl-CoAs on the outer mitochondrial membrane before entering either the glycerolipid 
biosynthetic pathway via GPAT-1 or the β-oxidation pathway via carnitine palmitoyltransferase-
1 (CPT-1a). CPT-1a is believed to compete with GPAT-1 for fatty acyl-CoA at the outer 
mitochondrial membrane. Both CPT-1a and GPAT-1 are sensitive to nutrient levels within the 
cell, specifically the ATP/AMP ratio. GPAT-1 is the only GPAT isoform responsive to these 
nutrient signals. AMP activated protein kinase (AMPK) activity increases when there is an 
abundance of AMP within the cell, signaling that ATP levels are low. Consequently, activated 
AMPK regulates both CPT-1a and GPAT-1 reciprocally. When cellular energy stores are low 
AMPK is activated and downregulates GPAT-1 activity, while promoting CPT-1a activity 
16
. 
The nutrient sensitivity of GPAT-1 enzymatic activity is due to post translational regulation via 
phosporylation by both PKC-θ and Casein Kinase II (CKII). Phosphorylation by either of these 
kinases increases GPAT-1 activity in vitro, as we, and others have shown 
17
, 
18
. 
Four isoforms of the GPAT enzyme have been identified; 2 microsomal isoforms 
(GPAT-3 and GPAT-4) and 2 mitochondrial isoforms (GPAT-1 and GPAT-2)
19
. We have shown 
a global decrease in glycerophospholipid mass in murine  Gpat-1 
-/- 
T cells 
20
.  It is of interest 
that murine T cells have only one mitochondrial isoform of GPAT, GPAT-1, while others have 
shown that murine hepatocytes actually have two distinct GPAT isoforms on the mitochondria 
(GPAT-1 and GPAT-2) 
18
,
21
,
19
. In rats, GPAT-1 mRNA is found predominantly in liver, skeletal 
 7 
muscle, and adipose tissue
22
,
23
. It is also found at lower levels in brain, kidney, heart, and adrenal 
gland. In mice, GPAT-1 mRNA is found predominantly in lung, liver, heart, and white adipose 
tissue
22
,
24
.  In humans, GPAT-1 mRNA is found primarily in adipose tissue 
22
,
24
. This is very 
interesting as, it suggests that GPAT family enzymes regulate glycerophospholipid mass 
differentially in tissues. The mammalian liver is the primary source of triglyceride and lipid 
production for the body, so it follows that a redundancy in mitochondrial GPAT may have 
evolved to provide a backup system for TAG and GPL synthesis. Regulation of GPAT-1 is 
controlled at multiple levels including nutritionally, developmentally, and hormonally through 
regulation of its transcription and through posttranslational modification. Studies have shown 
that treatment with insulin or administration of glucose can increase GPAT-1 expression 2-4 fold 
under the control of SREBP, Sp1, and insulin while polyunsaturated fatty acids and glucagon are 
strong inhibitors
25
. The orientation of GPAT-1 on the outer mitochondrial membrane puts its 
active site in a position facing the cytosol where it can be regulated by cytosolic effector kinases. 
Direct phosphorylation of GPAT-1 on mitochondria isolated from rat liver has been 
demonstrated by CK2 and PKCθ in vitro 26,27. PKCθ is the predominant PKC isoform activated 
downstream of TCR/CD3 stimulation and has been shown to be dysregulated with age
28
. This is 
very interesting as we have shown that GPAT-1 activity is also decreased with age suggesting 
that GPAT-1 dysfunction may be partially attributed to decreased PKCθ activity. A positive 
regulatory loop model in which GPAT-1 regulates phospholipid mass at the cell membrane and 
in turn promotes successful TCR engagement and PKCθ activation that works to positively 
reinforce GPAT-1 activity is possible.  
The T cell is the principle regulator of the type and extent of an immune response. At 
rest, and in the absence of foreign challenge, the T cell resides in a state of relative dormancy; 
 8 
however, upon encountering foreign antigen presented on the surface of ancillary antigen 
presenting cells (APCs) the T cell can be stimulated to aggressively divide, producing numerous 
clones of itself, which specifically recognize the triggering antigen, in a process called clonal 
expansion.  TCR engagement culminates in the activation of numerous signal enhancing and 
signal attenuating cascades which ultimately result in T cell proliferation and IL-2 production. 
The ultimate target of these signal cascades are transcription factors ( NFAT, AP-1, NF-κB) that 
work synergistically to bind the IL-2 promoter and initiate transcription of IL-2 (interleukin-2). 
IL-2 is the key cytokine involved in T cell activation and proliferation. T cells are dependent 
upon IL-2 through autocrine and paracrine signaling for maintenance of activation and to 
reinforce pro-proliferative signaling in surrounding cells. 
Successful TCR engagement results in phosphorylation of ITAM motifs on CD3-ζ 
subunits 
29
. A recent study by Gagnon, et. al. has demonstrated that TCR engagement  induces 
dissociation of the CD3ε cytoplasmic domain due to a reduction in negative charge and 
phosphatidyl serine in membrane TCR microclusters, thus inducing a conformational change that 
exposes the cytoplasmic ITAM domains of the subunit
30
.  ITAM phosphorylation is initiated by 
the Src-related protein tyrosine kinases: Lck and Fyn 
31
, 
32
. Lck and Fyn are thought to associate 
with the cytosolic tails of the CD4 and CD8 co-receptors on helper and cytotoxic T cells while 
Lck association with CD28 has also been demonstrated 
33
,
34
, 
35
, 
36
, 
37
. Lck is negatively regulated 
through phosphorylation of inhibitory tyrosine residues by Csk and positively regulated through 
the protein phosphatase CD45, however it has been recently demonstrated that Lck exists in a 
constitutively active form and its activity is spatially regulated through its association and co-
recruitment to the immunological synapse via its association with CD4 and/or CD28 
33
, 
38
,
39
, 
40
.  
A recent study by Rossy, et. al. has gone further to show that Lck clustering is driven by 
 9 
conformational changes changes in the protein itself
41
. Lck clustered at the TCR/CD3 complex 
can phosphorylate tyrosine residues on CD3-ζ subunits which serve as recruitment sites for the 
tyrosine kinases: Fyn and ZAP-70 
32
,
31
,
42
. ZAP-70 binds and engages the dual phosphorylated 
ITAMs on the CD3-ζ chain via its tandem SH-2 domains 42, 32.  ZAP-70 localization to the 
immunological synapse is highly dependent on co stimulatory signals through coreceptor 
complexes
43
. Once docked on the ITAM, Lck can phosphorylate and activate ZAP-70 placing it 
in a position to phosphorylate the transmembrane adaptor protein; LAT.  Phosphorylated LAT in 
turn serves as a docking site for a myriad of SH2 domain containing signaling proteins including: 
SHB, PLCG1, GRAP2, GRAP, Grb2, PIK3R1, ITK, MAP4K1
 
and VAV1 
44
.  Once VAV, 
SLP76 and Grb2 have docked on LAT they can act to recruit PI3K and PLCγ which are both 
necessary for the activation of Protein Kinase Cs (PKCs) 
45
.  ZAP-70 and SLP-76 regulate PKC-
θ and NF-κB activity in response to TCR activation 46. Following activation of the LAT 
scaffolding complex, PLCγ1 is found in the signaling complex bound to SLP-76, Vav1, and 
LAT, where it is phosphorylated and activated by Itk 
47
, 
48
, 
49
, 
50
. PLC-γ1, goes on to cleave 
phosphatidylinositol 4,5-bisphosphate generating the second messenger’s inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG). IP3 induces Ca
2+
 influx and DAG activates PKCs, 
with PKC-θ being the isoform most prevalent to T cell activation 51.  Ca2+ plays a key role in the 
activation of calmodulin which in turn activates calcineurin that can subsequently induce a 
conformational change in the nuclear factor for activated T cells (NFAT) exposing a nuclear 
localization sequence.  NFAT family mediated gene transcription is necessary for the 
propagation of pro-proliferative signaling in T cells following sufficient activation of the 
TCR/CD3/CD28 complex, so NFAT activation is a reliable marker of successful TCR 
engagement and signal transmission. To date five isoforms of NFAT have been identified: 
 10 
NFATc1, NFATc2, NFATc3, NFATc4, and NFATc5 while NFATc1 and NFATc2 are thought 
to be the principle isoforms involved in IL-2 induction 
52
,
53
. NFAT alone is not sufficient to 
activate IL-2 transcription or promote proliferation; in fact NFAT binding of target sequences 
alone will ultimately initiate a program of transcription leading to T cell anergy (reviewed in
54
). 
However, NFAT can form a complex with AP-1(cJun/cFos subunits) integrating upstream Ca
2+ 
and Ras signaling altering the transcriptional profile of the complex and promoting proliferation 
55
. The NFAT/AP-1 complex is capable of propagating pro-proliferative signaling through 
activation of mitogenic and IL-2 related genes. NFAT can also form complexes with a number of 
other transcription factors key to T cell signaling including, Oct1 and NF-κB, with each complex 
being capable of initiating the transcription of a unique suite of genes. The end result of proximal 
TCR signaling is the activation of a multitude of distal transcription factors, (i.e. NFAT, NF-κB, 
AP-1, Erk) which regulate T cell survival and proliferation. Altered signaling through proximal 
effectors such as LAT, ZAP-70, Grb2, or PKC-θ can have dramatic effects with regards to 
transcription factor activation and subsequent mitogenic signaling and IL-2 production. 
In the Fluid Mosaic Model of cell membranes put forth by Singer and Nicolson biological 
membranes are envisioned as two dimensional fluids in which lipid and protein diffuse freely in 
the membrane
56
. The idea that membranes are segregated as microdomains enriched in specific 
lipid species first emerged from studies on lipid trafficking in epithelial cells 
57
,
58
,
59
. Membrane 
microdomains appear to be enriched in glycosphingolipids and cholesterol. Based on these 
studies, is was postulated that glycosphingolipids form clusters or “rafts” within the Golgi 
membrane which serve as sorting platforms for the inclusion of proteins destined for outer cell 
membranes 
60
,
59
.  The idea that lipid rafts may serve as platforms for specific protein molecules 
came from studies in model membranes showing that glycosphingolipids and cholesterol 
 11 
strongly associate with each other forming densely packed clusters which can sequester proteins 
that colocalize with the raft microdomain 
61
,
59
. Protein interactions with sphingomyelin form a 
detergent insoluble partition of the membrane which is strengthened by association with 
cholesterol
62
. The first proteins to be identified in detergent insoluble membrane fractions 
hypothesized to be lipid rafts were the glycosylphosphatidylinositol (GPI) anchored proteins
63
. 
These findings came from studies that were able to track transport and incorporation of these 
proteins into putative lipid rafts through the Golgi apparatus. Further work by other groups 
revealed that myristoylation at the N-termini of src family tyrosine kinases allowed them to 
associate with detergent insoluble membrane fractions suggesting a role for lipid rafts in 
localizing signaling to specific membrane compartments 
64
,
65
. The discovery that palmitoylated 
trimeric G-proteins and G-protein coupled receptors associate with raft fractions strengthened the 
argument that lipid rafts play an important role in localizing membrane based receptors with the 
internal signal transduction machinery 
66
.  
T cell activation requires the coordinate activation of several membrane based receptor 
complexes that do not normally associate. Lipid raft microdomains could function as signaling 
platforms to bring together components of the immunological synapse.  It has been hypothesized 
that coreceptors such as CD4, CD8, and CD28 associate with lipid raft microdomains in cell 
membranes. In the case of CD28, it has recently been demonstrated that CD28 interacts with 
filamin-A and directs lipid raft accumulation at the T cell immunological synsapse by inducing 
cytoskeletal reorganization
67
. This finding is highly significant as it for the first time shows that 
co-receptor localization to the immunological synapse requires raft mediated mobility. It is well 
known that disruption of sphingomyelin or cholesterol in the cell membrane disrupts raft 
formation and subsequent downstream signaling of raft associated receptor signaling complexes. 
 12 
This is interesting in regards to GPAT-1 ablation, as a characteristic aspect of the Gpat-1
 -/-
 T cell 
is an increase in the cholesterol to phospholipid ratio. Although rafts are enriched in cholesterol, 
it is possible that in the absence of GPAT-1, the balance maintained between raft and non-raft 
partitions of the membrane are grossly perturbed and the size of raft fractions is increased in such 
a way as to prevent spatially dependent association of membrane based receptors and their 
intracellular signal transduction components. One of our principle hypotheses is that the 
observed decrease in membrane phospholipids observed in Gpat-1
 -/-
 T cells inhibits localization 
of CD28 to the immunological synapse resulting in a CD3 only signal through the TCR. This 
partial signal could potentially engage activation induced cell death in the T cells as we have 
shown that when stimulated with CD3/CD28 approximately 70% of Gpat-1
 -/-
 T cells undergo 
apoptotic cell death
7
. If the TCR/CD3/CD28 complex is not activated properly following 
stimulation, we should see a decrease in the phosphorylation of the tyrosine kinase ZAP-70, one 
of the earliest proximal effector kinases activated following T cell stimulation. Interestingly, 
when Gpat-1
 -/-
 T cells are stimulated with PMA/Ionomycin, which works through direct 
activation of PKC’s and triggering of Ca2+  release from intracellular stores bypassing membrane 
based signaling,  proliferation and IL-2 production do not appear altered
7
. This is highly 
significant as it suggests that GPAT-1 regulates T cell function through a membrane receptor 
based mechanism.  Therefore, a primary goal of this study is to determine whether ZAP-70 
activation is decreased in GPAMKD Jurkat T cells. This will offer strong support for our 
hypothesis that GPAT-1 regulates T cell effector function and fate through modulation of 
membrane phospholipids and perturbation of membrane based receptor signaling.  
The hypothesis that PA is necessary for effective T cell activations was first put forth 
nearly two decades ago by Stewart 
68
. Phosphatidic acid is a pleitropic lipid second messenger 
 13 
and protein anchoring molecule essential for mitogenic signaling and membrane remodeling in 
mammalian cells as well as the structural precursor of all GPL’s 69. PA is the most structurally 
simple of all the phospholipids and is an important intermediate in glycerphospholipid synthesis 
and signaling. TCR engagement results in rapid upregulation of phospholipid metabolism 
culminating in the appearance of numerous lipid mediators of signaling. PA has recently risen to 
prominence as a key regulator of MAPK signaling in T cells. The classical view of MAPK 
signaling is that once engaged by their cognate ligand, protein tyrosine kinase receptors (PTKR) 
dimerize leading to cross phosphorylation of tyrosine residues in their cytosolic domains via the 
intrinisic kinase activity of that domain. In the case of the T cell, the CD3-ζ chain ITAM 
functions as classical PTKRs in response to antigen engagement of the TCR. Phosphotyrosine on 
the ITAM serve as docking sites for numerous adaptor proteins containing SH2 domains. One of 
these adaptors, Grb2 recruits the Ras specific GEF SOS through its SH3 domains where it acts to 
recruit Ras to the plasma membrane. Until very recently it was thought that Ras directly recruited 
the serine/threonine kinase Raf-1 to the cell membrane, however a seminal study by Rizzo, et. al. 
showed for the first time that Raf-1, an essential component of the MAPK signaling cascade 
physically binds PA in order to localize to membranes and this binding is independent of Ras 
association
70
. In fact, it is PA dependent membrane association of Raf-1 that actually activates its 
kinase activity through a poorly understood mechanism involving Ras. Further studies showed 
that mutation of PA binding domains in Ras completely abrogates Raf-1 dependent MAPK 
signaling and results in cell cycle arrest (reviewed in 
71
). Once activated Raf-1 can phosphorylate 
and activate MEK, a tyrosine/threonine kinase which can go on to phosphorylate and activate 
Erk 1 and Erk 2. The Erk family is directly involved with transcription factor activation in the 
nucleus, and in the case of T cells drive the expression of IL-2 through NFAT, AP-1, and NF-κB. 
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Previous work probing PA mediated MAP kinase signaling in T cells has focused on two 
mechanisms of PA production;  (i)PLD mediated hydrolysis of phosphatidylcholine and (ii) 
phosphorylation of diacylglycerol by DAGK-α . The predominant opinion in the literature is that 
PLD2 is the principle contributor of PA in TCR based mitogenic signaling. However, it is well 
known that the direct product of GPAT-1; lyso-PA is converted to PA via lyso-PA acyl 
transferases. The role of GPAT-1 in contributing to cellular PA has yet to be probed by any other 
group. Our previous work shows that GPAT-1 deficiency results in a >72% decrease in total 
cellular PA, thereby presenting the possibility that GPAT-1 is a key regulator of PA in T cells
7
. 
In T cells, PLD2 is activated through TCR dependent membrane based signaling. It is interesting 
then that we have shown that GPAT-1 activity is also regulated through membrane based TCR 
signaling
18
. Specifically, we have shown that GPAT-1 is positively regulated by PKC-θ through 
phosphorylation. PKC-θ activated in T cells following TCR engagement 51, and is itself activated 
by Ca
2+
 and DAG; both products of PLC-γ/phosphoinositide based signaling mechanisms. New 
evidence shows that mitochondria localize to the TCR-supra molecular activation complex 
(SMAC) following successful TCR engagement which would theoretically place GPAT-1 in a 
prime location to be activated by PKC-θ and subsequently generate large amounts of LPA for 
immediate conversion to PA by lyso-PA-acyl transferase. This PA generated at the SMAC would 
be readily available to facilitate Raf-1 binding and perpetuate Ras initiated MAPK signaling 
through ERK 1/2. It is also possible that GPAT-1 maintains cellular homeostatic levels of PA 
and PLD2 acts to raise intracellular PA in such a way as to create a backlog of PA at other 
glycerophospholipid anabolic enzymes thus allowing for sustained free PA for signaling. The 
most straight-forward way of testing the hypothesis that GPAT-1/GPAM contributes to the PA 
pool and the observed dysfunctional T cell phenotype is a result of deficient cellular PA is to add 
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PA back to culture and look for rescue of the phenotype. Preliminary experiments in the 
GPAMKD Jurkat T cell revealed a dramatic decrease in IL-2 secretion compared to control cells. 
Therefore, we will add PA at physiologically relevant concentrations to cultured GPAMKD 
Jurkat T cells and screen for the rescue of IL-2 activity.  
Naïve TH0 cells enter circulation following thymic selection where they subsist in a state 
of minimal energy expenditure consuming just enough glucose and other nutrients to maintain 
homeostatic processes 
72
,
73
,
74
,
75
. Quiescent T cells retain the ability to rapidly upregulate 
metabolic pathways and induce a program of clonal expansion following encounter with their 
MHC presented cognate antigen.  The program of gene regulation and protein modification 
following antigenic stimulation transforms the resting cell into a highly active cytokine 
producing effector cell within a matter of hours. This transformation requires enormous energy 
expenditure on the part of the cell with pathways of both proliferation and cytokine production 
being engaged simultaneously. To meet these energy needs the cell must make dramatic 
alterations in their metabolism. This metabolic switch allows T cells to heavily engage glycolytic 
pathways in response to stimulation while only modestly increasing oxygen consumption 
76
,
72
. 
Since this switch is concomitant with stimulation, it follows that receptors involved in T cell 
activation must play a role in regulating metabolism. Further work in this area and current 
studies are revealing this to be the case. One intriguing example is CD28 mediated regulation of 
glucose metabolism.  A seminal study by Frauwirth, et. al. showed that CD28 costimulation acts 
through PI3K and Akt to increase the glycolytic metabolism in T cells
73
. Furthermore, they 
showed that most of the lactate generated as a by-product of stimulation induced glycolysis is 
secreted indicating that increased metabolism in stimulated T cells is not simply a response to 
increased energy demand, but a direct result of CD28 costimulation. However, stimulation with 
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CD28 alone does not appear to activate PI3K and Akt, or glycolytic metabolism in general 
suggesting that TCR/CD3 stimulation is necessary for upregulation of glycolytic metabolism. It 
has been suggested that upregulation of glycolysis following T cell stimulation is due to a 
synergetic effect between the signaling pathways engaged by CD3, CD28, and other coreceptor 
molecules. As described by Frauwirth and Thompson, costimulation can be summarized in a two 
pronged model where the TCR/CD3 complex form one branch and costimulatory molecules such 
as CD28 form a second branch. Signaling through the TCR initiates gene transcription which 
places a significant demand for energy on the cell. In order to compensate, the cell undergoes 
increased levels of oxidative phosphorylation from its limited glucose pool. Costimulation 
through CD28 and other coreceptors induces the expression of glucose transporters to meet the 
growing energy needs of the cell. This synergistic effect is supported by the fact that glycolytic 
metabolism is posttranscriptionally regulated so glucose uptake can be dramatically increased 
through costimulation to levels exceeding the energy needs of the cell 
74
,
73
.  A similar 
phenomenon has been described in fat and muscle cells where insulin induces glucose uptake in 
excess of cellular needs which promotes TGL synthesis and glycogen storage.  
Glucose metabolism undoubtedly plays a pivotal role in T cell survival and effector 
function. However, the role of fatty acid metabolism in T cells has been largely eclipsed by focus 
on the glycolytic switch. Until recently few groups have asked the question as to what, if any 
role lipid metabolism play in T cell function and fate. Current work is starting to unveil a 
previously unappreciated role for lipid metabolism during T cell activation and downstream 
function. The first convincing evidence showing that lipid ligands mediate the T cell response 
came from a study by Clark, et. al. demonstrating the immunoregulatory role of PPAR-γ in T 
helper cytokine secretion
77
. This study showed for the first time that the lipid responsive nuclear 
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receptor PPAR-γ 1 is expressed in murine splenocytes. Further analysis revealed that the PPAR-γ 
ligand 15d-PGJ2 or pharmacological inhibition with thiazolidinedione or ciglitazone 
significantly reduced IL-2 secretion, a key cytokine in the T cell driven adaptive immune 
response. In the context of Gpat-1
 -/-
 T cells, this is highly significant as we have demonstrated 
that levels of the potent PPAR activators LTB4 and PGE2 are significantly elevated 
7
.  The 
general role of PPAR family transcription factors is anti-inflammatory in nature as their activity 
has well studied in macrophages and dendritic cells
78
,
79
,
80
. A large variety of endogenously 
generated lipid metabolites originating from saturated or unsaturated fatty acid metabolism are 
capable of activating PPAR nuclear receptors which can act to positively or negatively regulate 
gene transcription
81
. These early studies suggest a key role for lipid metabolites in regulating the 
type and extent of both the innate and adaptive immune response.   
Although the importance of lipid metabolites as PPAR activators has become well known 
over the past decade, a more direct role for lipid metabolism in T cell differentiation and effector 
function was not realized until very recently. A plethora of factors engage in the regulation of 
cellular metabolism including numerous hormones, growth factors, effector kinases, transcription 
factors and nutrients themselves such as glucose. One nutrient sensing kinase and its associated 
signaling partners has risen to prominence recently as a key regulator of the glycolytic and lipid 
oxidative switch, the mitochondrial target of rapamycin (mTOR). The functional significance of 
mTOR in regulating cell growth and proliferation has been well elucidated over the years
82
.  
However, evidence for the direct involvement of mTOR in regulating lipid metabolic pathways 
has only recently begun to surface. The first demonstration of a direct role for mTOR in 
regulating lipid metabolism came from work in primary cultures of rat hepatocytes
83
. In that 
study, the authors specifically inhibited mTOR with Rapamycin and observed that inhibition 
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increased oxidation of exogenous fatty acids 46%- 100%, respectively while de novo lipid 
synthesis were reduced by 60%. They also found that rapamycin decreased expression of 
mitochondrial glycerol-3-phosphate acyltransferase (GPAT-1), the rate limiting enzyme in de 
novo TGL and GPL synthesis. Consistent with a role for mTOR in regulating lipid metabolism, 
glucose utilization was unaffected by rapamycin. These results strongly suggest that mTOR 
regulates energy production through direct modulation of hepatic fatty acid metabolism. Other 
studies followed directly implicating mTOR in the regulation of regulatory T cells development 
and differentiation. CD4+FOXP3+ Regulatory T cells (Tregs) are a suppressor T cell subset that 
is thought to modulate immune self/non-self-discrimination by limiting T effector (Teff) cell 
function during and following an immune response. A key study by Haxhinsato, et. al. identified 
Akt as a repressor of Treg development both in vitro and in vivo 
84
. Akt can be activated through 
the PI3K pathway and active Akt can go on to activate mTOR and negatively regulate lipid 
metabolism by upregulating glycolytic metabolism. This shows that  suppression of lipid 
oxidation through constitutive activation of the Akt-mTOR axis negatively regulates Treg 
development. This was a highly significant finding as it for the first time implicates a 
requirement for lipid metabolism in the development of specific T cell subsets. Following these 
observation, a cutting edge study by Michalek, et. al. demonstrated for the first time that distinct 
glycolytic and lipid oxidative metabolic programs actually define specific T cell subsets
4
. This 
study showed that effector and regulatory T cell subsets prefer either glycolytic or lipid oxidative 
metabolic pathways. Intriguingly, they found that induction of either metabolic pathway was 
sufficient to enrich the target T cell phenotype. Specifically, T effector cells preferably engage in 
glycolytic metabolism while T regulatory cells primarily engaged lipid metabolic pathways to 
meet energy needs and induction or inhibition of either metabolic process was sufficient to 
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enrich T effector or T regulatory cell populations. These studies convincingly demonstrate the 
importance of lipid metabolism in T cell differentiation and effector function. The exact 
mechanism(s) by which lipid metabolism regulates these processes is still unclear but the 
involvement of PPAR and FOXP3 mediated gene regulation has been suggested.  While the 
focus of T cell activation and differentiation has been on cytokines, antigenic signaling and 
various modes of stimulation, evidence is mounting that strongly implicates cellular metabolism 
at the fundamental level as the major determining factor of T cell function and thus the adaptive 
immune response
85
. A ground breaking study by Pearce, et. al. highlighted the critical role of 
fatty acid metabolism in CD8+ T cell memory
86
. The authors showed that tumor necrosis factor 
receptor associated factor 6 (TRAF6) regulates CD8+ memory T cell development through 
modulation of fatty acid metabolism. Specifically, microarray analysis revealed that TRAF6 is 
regulates many key genes involved in fatty acid metabolism and TRAF6 deficient T cells are 
defective in AMP-acivated kinase activation and mitochondrial fatty acid oxidation. This study 
for the first time demonstrated a necessity of lipid oxidation in the development of CD8+ 
memory T cell populations. Further studies conducted by van der Windt, et. al. demonstrated that 
CD8+ memory T cells, but not CD8+ effector cells possess substantially more spare respiratory 
capacity (SRC)
76
.  SRC is defined as the potential for a cell to meet energy demands in response 
to stimulation or stress. Probing of possible mechanisms regulating increased SRC in CD8+ 
memory T cells revealed a key role for IL-15, which is known to play an indispensable role in 
CD8 memory development. The authors found that IL-15 regulates mitochondrial biogenesis and 
promotes fatty oxidation through up regulation of CPT-1a.  CPT-1a is the rate limiting step in 
lipid oxidative metabolism.  
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An indirect consequence of elevated lipid oxidation is the generation of reactive oxygen 
species (ROS). ROS levels are associated with damage to cellular macromolecules such as 
protein, RNA, and DNA, which can potentially lead to deleterious mutations and have been 
hypothesized to play a role in aging and cancer development. Hepatocytes from Gpat-1 
-/- 
 mice 
exhibit elevated ROS, apoptosis, and increased proliferation
14
. In this study, the authors did not 
find a direct link between ROS and DNA damage however a dramatic increase in Ca
2+
 induced 
opening of the mitochondrial permeability transition pore (MPTP) was observed. MPTP opening 
is associated with leakage of proapoptotic factors from the mitochondria and in response to 
oxidative stress. This strongly suggests that in the absence of GPAT-1 increased lipid oxidation 
results in elevated levels of ROS and associated cellular dysfunction. This finding is intriguing in 
terms of Gpat-1 
-/- 
 thymocytes as we have demonstrated that CPT-1a protein levels are 
upregulated
13
. Increased CPT-1a protein provides a mechanism by which ROS could be elevated 
in the absence of GPAT-1. ROS has been shown to induce oxidative stress in T cells with a 
principle consequence being decreased T cell activation and cytokine production. A study by 
Chakravarti, et. al. specifically showed that ROS induced oxidative stress in T cells prevents the 
phosphorylation and activation of Zap-70, a critical effector kinase involved in antigen induced T 
cell activation
87
.  Several studies have suggested that fatty acid metabolism is dysregulated in the 
absence of GPAT-1, however to date, no one has directly measured glycolytic and oxidative 
metabolism in GPAT-1 deficient cells. One group however, has shown that overexpression of 
GPAT-1 depresses hepatocyte fatty acid oxidation ex vivo
88
. In light of the large body of 
evidence supporting a role for lipid metabolism in T cell differentiation and effector function it is 
necessary to determine whether lipid metabolism is altered in the absence of GPAT-1. Therefore, 
a major goal of this project is to determine whether the metabolic profile of Gpat-1 
-/- 
 T cells is 
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altered. Several metabolically relevant scenarios could explain the phenotype observed in Gpat-1 
-/- 
 T cells. It is possible that increased ROS formed as a consequence of elevated CPT-1a induced 
fatty acid oxidation contributes to the phenotype of Gpat-1 
-/- 
 T cells. If these ROS act locally at 
the mitochondrial level, they could act to compromise mitochondrial integrity and make the cell 
more prone to engaging apoptotic pathways when stressed by stimulation. Other mechanisms 
such as increased engagement of PPAR pathways or induction of a Treg-like phenotype could 
functionally contribute to the phenotype as well. We have observed significantly elevated 
CD4+CD25+FOXP3 positive T regulatory cell populations in the GPAT-1 knockout mouse. 
Increased levels of fatty acid oxidation have been demonstrated to promote a Treg phenotype as 
described above. An important point to make is that many key aspects of GPAT-1 deficiency in 
T cells correlate not only with age, but fit the phenotype of Treg cells as well, i.e. reduced IL-2 
secretion. It is therefore possible that GPAT-1 regulates T cell function through modulating the 
balance between fatty acid oxidation and lipid synthesis thereby influencing effector 
differentiation following stimulation.  
The preceding findings from the literature are very interesting in the context of Gpat-1
 -/-
 
T cells, where the rate limiting enzyme of de novo TGL and GPL synthesis is absent. The 
phenotype of Gpat-1
 -/- 
 T cells is characterized by decreased IL-2 secretion, increased apoptosis 
in response to CD3/CD28 stimulation and significantly altered phospholipid compostion
7
. We 
hypothesize that the dysfunctional Gpat-1
 -/-
 T cell phenotype is likely attributed to one, or 
combination of three biological processes. The first possibility is that alterations in membrane 
phospholipid content perturb signaling through membrane based receptors such as the 
TCR/CD3/CD28 complex. The second possibility is that GPAT-1 regulates the intracellular 
phosphatidic acid pool and GPAT/GPAM deficiency results in a sink within the cellular PA pool 
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and subsequent inhibition of PA dependent signaling pathways. The third possibility is that in the 
absence of GPAT-1/GPAM lipid oxidation is elevated with negative consequences for T cell 
effector function and specifically IL-2 production. This dissertation explores these three 
possibilities.  
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Chapter 2 
Glycerol-3-phosphate Acyltransferase, Mitochondrial Regulates IL-2 Production, 
Phospholipid Mass and Apoptosis in Jurkat T cells 
 
2.1 Abstract 
 We have previously demonstrated that Glycerol-3-phosphate acyltransferase-1, the first 
and rate limiting step in de novo glycerophospholipid synthesis regulates murine T cell function. 
The resultant phenotype is characterized by decreased IL-2 production, increased propensity 
toward apoptosis, and altered membrane glycerophospholipid mass similar to that of an old T 
cell. Since T cells in previous experiments were from whole animal GPAT-1 knockout mice, 
questions remained as to what extent the macro environment of the model influenced the 
observed cellular phenotype. Therefore, one goal of this study was to determine whether the 
GPAT-1 knock out phenotype is the result of a cell intrinsic defect rather than being the 
consequence of altered thymic development, epigenetic changes, or other mechanisms in the 
periphery of the GPAT-1
-/- 
mouse. In addition, the role of GPAT-1 in T cells from human lineage 
is completely unknown, so we sought to generate and phenotypically characterize a 
mitochondrial glycerol-3-phosphate acyltransferase (GPAM) deficient Jurkat T cell. 
Furthermore, this line was used to probe possible mechanisms by which GPAT-1/GPAM 
regulates T cell function. We report here that many the key characteristics of the dysfunctional 
murine GPAT-1
-/-
 T cell recapitulate in the GPAMKD Jurkat T cell. We found striking decreases 
in IL-2 production along with altered phospholipid mass and increased apoptosis. We next 
sought identify mechanisms by which GPAM regulates this phenotype. Since phosphatidic acid 
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(PA) serves as the precursor to all glycerophospholipids and this mass is decreased in both 
GPAT-1
-/- 
T cells and GPAMKD Jurkat T cells, we asked whether PA addition to culture was 
capable of rescuing IL-2 production in the GPAMKD and subsequently found no effect under all 
of the conditions tested. We next asked whether changes in phospholipid mass and membrane 
composition were interfering with T cell activation. GPAMKD T cells were found to have 
significantly decreased Zap-70 phosphorylation following stimulation, implying that GPAM 
deficiency results in altered membrane based signaling possibly as the result of loss of the co 
stimulatory CD28 signal. These data show for the first time that GPAM deficiency results in an 
inherent defect in T cell functionality and that this defect is likely the result of altered membrane 
based signaling.  
2.2 Introduction 
Glycerol-3-phosphate acyltransferases (GPATs) catalyze the initial and rate limiting step 
in the de novo biosynthesis of triacylglycerol (TAG) and glycerophospholipids (GPL). Utilizing 
glycerol-3-phosphate and fatty acylCoA as substrates, GPATs generate lysophosphatidic acid 
which can serve as a signaling molecule,  be further acylated to phosphatidic acid (PA) which 
can also act as a signaling molecule and docking site for mitogenic factors such as Raf-1 or can 
enter lipid biosynthetic pathways involved in the production of TAG and GPL. Four GPAT 
isoforms (GPAT 1-4) have been identified in mammalian cells with the distribution and activity 
of each varying between tissue and cell type (reviewed in 
89
). Of these four isoforms, GPAT-1 
(GPAM in humans) and GPAT-2 are integral mitochondrial membrane proteins while GPAT-3 
and GPAT-4 are typically isolated in microsomal fractions. The role of GPAT-1 in generating 
liver derived GPL, regulating radical oxygen species (ROS) generated as a by-product of β-
oxidation, and regulation of hepatocyte proliferation has been extensively studied in murine 
 25 
models 
14
. We published the first evidence supporting an immunoregulatory role for GPAT-1 in 
murine T cells 
7
, however little is known of the underlying mechanisms by which GPAT-1 
regulates T cell function. Additionally, to the best of our knowledge it remains unknown as to 
whether GPAM, the human homologue of GPAT-1, acts in a similar immunoregulatory capacity 
in T cells.  
The T cell is the principle regulator of the type and extent of an immune response. At 
rest, and in the absence of foreign challenge, T cells reside in a state of relative dormancy; 
however, upon encountering foreign antigen presented on the surface of ancillary antigen 
presenting cells (APCs) the T cell can be stimulated to clonally expand with clones specifically 
recognizing the triggering antigen. T cell receptor engagement culminates in the activation of 
numerous signal enhancing and signal attenuating cascades which ultimately result in T cell 
proliferation and cytokine production. The ultimate targets of many these signal cascades are 
transcription factors (NFAT, AP-1, NF-κB) that work synergistically to bind the IL-2 promoter 
and initiate its transcription.  IL-2 is the key cytokine involved in T cell activation and 
proliferation. T cells are dependent upon IL-2 through autocrine and paracrine signaling for 
maintenance of activation and to reinforce pro-proliferative signaling in surrounding cells. 
Reduced IL-2 secretion is a hallmark of aging in both humans and rodents. Although the overall 
number of T cells does not change with age, it has been demonstrated that T cell function is 
comparatively impaired relative to young controls (reviewed in 
90
).  
Changes in membrane phospholipid composition are characteristic of aged cells 
belonging to various tissues and lineages. The observation that membrane fluidity is significantly 
decreased with age has led to the “membrane gate theory” which postulates that the cellular 
dysfunction observed with aging may be attributed to alterations in membrane phospholipid 
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composition 
10
.  Models in which to study the effects of altered membrane lipid composition in T 
cells are largely lacking, making the study of the molecular mechanisms underlying age related 
cellular dysfunction difficult. There are very few methods with which to artificially alter 
membrane phospholipid composition. One such method that has been attempted is the removal 
of cholesterol by treatment with cyclodextrin but this has been reported to induce off target 
changes in the cell. Therefore, one goal of this study was to establish a stable Jurkat T cell line 
deficient in GPAM in which to study the effects of altered phospholipid composition on T cell 
function. Jurkat cells are the most well studied model of T cell activation and signaling in which 
a multitude of now well-known mechanisms were first identified 
91
. Due to the vast amount of 
data in the literature describing precise molecular mechanisms of T cell activation, proliferation 
and cytokine production in Jurkat T cells we selected this cell line to further elucidate the role of 
GPAM in T cell function. 
We have previously shown that primary T cells from GPAT-1 
-/- 
mice have an altered 
phospholipid profile and secrete reduced levels of IL-2 in response to stimulation 
7
. One question 
that often arises in the study of a specific cell type isolated from a whole animal knockout is to 
what extent the macro environment of the model influences the observed cellular phenotype. 
Therefore, another goal of this study was to determine whether the dysfunctional T cell 
phenotype we observe in murine GPAT-1
 -/-
 T cells is due to an inherent loss of GPAT-1 
resulting in a cell intrinsic defect rather than being the consequence of altered thymic 
development, epigenetic changes, or other mechanisms in the periphery of the GPAT-1
-/- 
mouse. 
In this manuscript we present evidence that GPAM itself plays a critical role in the regulation of 
IL-2 production in Jurkat T cells similar to that of GPAT-1 in primary murine T cells. We further 
show that this effect is not rescued by addition of PA and that ZAP-70 phosphorylation, a very 
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early event in T cell activation is significantly decreased following stimulation, suggesting that 
GPAM regulates IL-2 production through a membrane based mechanism.   
 
2.3 Methods and materials 
Generation of a stable GPAM knock down Jurkat T cell 
Jurkat T cells were plated 24 hours prior to lentiviral infection in 12 well plates (1 
ml/well at 10
5
cells/well) in complete media (10% heat-inactivated fetal bovine serum plus 100 
U/ml penicillin, 100 µg/ml streptomycin, 10 µM β-mercaptoethanol, and 100 mM L-glutamine). 
Cells were washed and media replaced with complete media supplemented with 5µg/ml 
polybrene (for neutralizing charge interactions between viral capsid and cell membrane). 10
6
 
GPAM shRNA lentiviral particles (Santa Cruz Biotechnology) or control scrambled shRNA 
(Santa Cruz Biotechnology) were added to each well. Culture medium was replaced with 1 ml 
complete medium without polybrene. For selection of stable clones expressing GPAM shRNA 
cells were split 1:5 and incubation continued for 48 additional hours. Media was changed and 
cells re-plated in media containing 10µg/ml Puromycin dihydrochloride for selection of 
transduced clones. Medium was replaced with medium containing fresh puromcyin every 3-4 
days until resistant cells were identified and expanded. 
 
Quantitative real time PCR  
Total RNA was extracted from ~10
6
 cells using the Qiagen RNeasy Plus Mini Kit. cDNA 
for GPAM and GAPDH were amplified from 100 nanograms of total RNA from GPAMKD or 
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ScshRNA Jurkat T cells using  Qiagen QuantiTect Primer Assays  (commercially available 
proprietary primer sets, Qiagen) in a one-step qRT-PCR reaction with the Quantitect SYBR 
Green RT-PCR kit. One-step qRT-PCR was performed using an Eppendorf RealPlex Master 
Gradient Thermocycler. The one-step RT-PCR reaction was performed in at least triplicate under 
the following conditions: reverse transcription: 30 minutes at 50°C, PCR initial activation: 15 
minutes at 95°C, followed by PCR amplification: 15 seconds at 94°C, 30 seconds at 55°C, and 
30 seconds at 72°C X 40 cycles. The ΔΔCT method was used in the evaluation of qPCR data. 
Samples were run in triplicate and the following formula was used to calculate the fold-change in 
GPAM mRNA expression.  Results are normalized 
to control ScshRNA set at a value of 1 for GPAM mRNA expression.  
 
Western blotting 
One million cells were washed twice with cold PBS and lysed with 30μl of Laemmli's 
sample buffer and homogenized under denaturing conditions. Cell lysates were centrifuged at 
13,000 X g and supernatant containing protein collected. Samples were rapidly were heated at 
95°C under denaturing conditions. 20μl of lysate (approximately 1×106 cell equivalents) was 
loaded onto a 10% polyacrylamide gel (Tris-HEPES-HCl), resolved by electrophoresis 
(90mA/gel) and transferred onto PVDF membrane. PVDF membranes were blocked with 5% 
BSA in TBS and incubated overnight at 4°C with rabbit anti human polyclonal GPAM antibody 
(Santa Cruz). Membranes were incubated for 1h at room temperature with anti rabiit HRP 
conjugated antibody; immunoreactive proteins are visualized with ECL reagent. The Syngene 
Image Documentation system was used to capture ECL signal and qualitatively quantify protein 
 29 
following Western blot. Densitometric analysis was performed using Syngene Genesnap 
software. 
 
Proliferation and apoptosis 
Proliferation was measured using the BD biosciences FITC BrdU Flow Kit. For 
stimulated conditions, 96 well plates were coated with 10 µg/ml of CD3 antibody in NaHCO3 
buffer and incubated for 4 hours at 37°C. Then 1 mM BrdU diluted in PBS and 1 μg/mL of 
CD28 antibody was added to GPAMKD or ScshRNA cells in complete media at a density of 10
6
 
cells/mL and incubated at 37°C for 24 hours. For unstimulated conditions, non CD3 coated 
plates were used and CD28 antibody was not added. Following incubation cells were fixed and 
permeabilized according to the manufacturer’s protocol and FITC fluorescence was measured by 
flow cytometry on an Accuri C6 flow cytometer. For flow cytometry, each sample was replicated 
3 times, with each replicate representing an independently stimulated or unstimulated culture.  
100,000 events were analyzed for each sample. 
For apoptosis assays, cells were stimulated or not as described above for 24 hours and the 
Metabolic Activity Dead Cell Apoptosis Kit (Molecular Probes) was used to determine live, 
dead, and apoptotic populations according to the manufacturer’s instructions.  Briefly, a 
combination of APC labeled Annexin V to detect exposed phosphatidyl serine, C12 resazurin to 
detect mitochondrial membrane potential, and SYTOX Green nucleic acid stain for determining 
membrane permeability were used to identify characteristics associated with living, dead, and 
apoptotic cells by flow cytometry as described above.  
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Enzyme linked immunosorbent assay for IL-2 and ZAP-70 
To measure secreted IL-2 in culture supernatants, we used the Human IL-2 Ready-SET-
Go! ELISA kit (eBiosciences). GPAMKD and ScshRNA control cells were stimulated or not 
with plate bound CD3 and soluble CD28 or PMA/Ionomycin as described above and plated at a 
density of 10 X 10
6
 cells/mL. Culture supernatants were collected after either 6 or 24 hours and 
ELISA was performed according to the manufacturer’s instructions. Briefly, supernatants were 
collected and incubated in 96 well plates precoated with anti-IL-2 capture antibody (and blocked 
with 5% BSA for 1 hour) for 16 hours at 4°C.  Next, biotin conjugated anti-IL-2 detection 
antibody was added to each well and plates were incubated for 60 minutes at 25°C followed by 
addition of avidin conjugated HRP and additional 30 minute incubation. TMB substrate was 
added followed by quenching of the reaction with 2N H2SO4 and absorbance was read at 450 
nm. Standards containing known amounts of IL-2 were used with each ELISA to calculate IL-2 
concentration relative to sample absorbance. Each IL-2 assay was carried out with at least six 
replicates.  
To measure ZAP-70 phosphorylation, we used a commercially available rabbit anti-
human Zap-70 capture antibody (Cell Signaling, supplied at 100X) in combination with a rabbit 
detection antibody directed against phospho Zap-70 (Y319)(Cell Signaling, supplied at 100X). 
GPAMKD and ScshRNA control cells were stimulated or not with soluble CD3/CD28 in tubes at 
a density of 10 X 10
6
 cells/mL for 2 minutes immediately followed by the addition of a 10 fold 
excess of ice cold complete media. Samples were then centrifuged at 14,000 x g for 2 minutes 
followed by aspiration of the supernatant and addition of 100 μL of lysis buffer (20 mM Tris; pH 
7.5, 150 mM NaCl, 20 mM DTT, 1 mM EDTA, 1 mM EGTA, 1% Triton, 1 mM Na3VO4 , 2% 
SDS, and 1 mM beta-glycerophosphate, 2.5 mM sodium pyrophosphate, and 1μg/mL leupeptin 
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supplemented with 1mM PMSF immediately prior to use).  Lysates were centrifuged at 4°C for 
10 minutes and supernatants collected. Debris-free lysates were then loaded into 96 well plate 
wells precoated with Zap-70 capture antibody (and blocked with PBS+5% BSA for 1 hour) and 
incubated at 37°C for 2 hours.  Wells were emptied and washed with PBS supplemented with 0 
.05% Tween-20. Detection antibody diluted in blocking buffer was added to each well at 1X and 
plates were incubated at 37°C for 1 hour. Plates were washed and 1X Anti-rabbit IgG, HRP-
linked Antibody was added to each well and plates were incubated at 37°C for 30 minutes. Plates 
were then washed and TMB substrate was added to each well followed by quenching of the 
reaction with 2N H2SO4 and absorbance was read at 450 nm. No standards are currently 
available for quantitative determination of phospho Zap-70 (Y319), therefore results are 
presented as the mean raw absorbance values for samples in quadruplet wells.  
 
Phospholipid extraction and mass analysis 
Frozen ScshRNA and GPAMKD Jurkat T cells were thawed, and lipids extracted by the 
addition of 1 ml of 2-propanol to the tube containing the cells. These contents were then 
transferred to a test tube containing 3 ml hexane, and the original tube containing the cells was 
rinsed with another aliquot of 2-propanol (12, 25). The single-phase extract was thoroughly 
mixed, and the residue was pelleted by centrifugation at 1,000 g. The lipid containing organic 
fraction was removed, and dried under nitrogen, and resuspended in organic solvent solvent. The 
pellet was kept for protein quantitation. The lipid sam- ples were quantitatively spotted on a heat-
activated Whatman LK6 thin-layer chromatography plate and developed in a solvent system 
containing chloroform:methanol:acetic acid:water (60:30:3:1 by vol- ume). Individual bands 
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corresponding to commercially prepared standards were scraped into acid-washed tubes, and the 
phosphorus content was analyzed. The protein pellet was air-dried overnight and then incubated 
with 0.2 M KOH at 65°C overnight to resolubilize the proteins. Protein concentration was 
determined using the Bradford method. 
 
Phosphatidic acid addition  
18:1 PA (1, 2-dioleoyl-sn-glycero-3-phosphate # 840875C) and 12:0 PA (1,2-dilauroyl-
sn-glycero-3-phosphate product # 840635) were purchased from Avanti Polar Lipids, Inc. (AL, 
USA) and resuspended in choloroform. Chloroform suspended PA was dried under nitrogen gas 
and then suspended to a concentration of 10 mM in 150 mM NaCl and 10 mM Tris·HCl, pH 8. 
The solution was then mixed vigorously for 2 min, incubated at 37°C for 10 min, and mixed 
again for 2 min as previously described.  Lipid micelles were generated by sonicating the lipid 
emulsion until clear. PA micelles were added to stimulated or unstimulated culture dishes of 
ScshRNA or GPAMKD cells at a final concentration of 20 μM. Cells were incubated with PA 
for 24 hours after which point supernatants were assayed for IL-2 by ELISA. 
 
Statistical analysis 
Statistical significance was determined using either one-way or when appropriate two-
way ANOVA. Data were considered significant relative to control values when P <0.05. Post 
hoc analysis was conducted using Tukey’s or Bonferroni’s multiple-comparison test with 
GraphPad Prism software (San Diego, CA, USA)  
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2.4 Results 
We chose a lentiviral mediated strategy for shRNA delivery to generate a stable 
knockdown cell line based on the prediction that GPAM protein turnover could be such that 
transient knockdown with plasmid vectors may be insufficient to knock down protein expression 
before loss of the plasmid. Transduction of Jurkat T cells with GPAM shRNA encoding 
lentiviral particles resulted in a 7.3 fold decrease in GPAM mRNA after 4 passages in culture 
under puromycin selection relative to the ScshRNA control (Fig. 2.1). After 11 passages in 
culture GPAM protein was decreasd 2.8 fold by Western blot and densitometry analysis relative 
to the ScshRNA control (Fig. 2.2).  
Proliferation was measured by BrdU incorporation assay and samples were analyzed by 
flow cytometry. Measurement of BrdU incorporation following 24 hours with or without 
CD3/CD28 stimulation revealed that proliferation rates of GPAMKD and ScshRNA control cells 
were not significantly different although nor was any difference in proliferative capacity 
observed between stimulated and unstimulated conditions, with the exception of their being a 
significant decrease in stimulated ScshRNA cells compared to unstimulated GPAMKD T cells 
(Fig. 2.3). Next, apoptosis and cell death were measured in stimulated and unstimulated 
GPAMKD and ScshRNA control cells using a combination of annexin V C12-Resazurin and 
SYTOX Green by flow cytometry. Significantly higher occurrences of cell death and apoptosis 
were observed in GPAMKD cells compared to ScshRNA controls (Fig. 2.3).  
IL-2 induction is a well-studied and characteristic event indicative of healthy T cell 
function 
92
. Based on previous observations that cytokine production is altered in primary T cells 
from the GPAT-1 
-/-
 mouse we predicted that these effects may be more pronounced in the Jurkat 
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T cell line, one known for secretion of large amounts of IL-2 in response to stimulation. ELISA 
for IL-2 secretion was performed following 6 and 24 hours with or without CD3/CD28 
stimulation in GPAMKD and ScshRNA control cells. We observed nearly a 9 fold decrease in 
IL-2 production in the GPAMKD compared to ScshRNA at both 6 hour and 24 hour (Fig. 2.4) 
time points. We chose these time points based on the earliest observed maximal IL-2 production 
(6 hours) and proliferative patterns of our Jurkat cell line (~24 hour doubling time).  IL-2 
production in unstimulated cells was not significantly different between the GPAMKD and 
ScshRNA control. PMA/Ionomycin stimulation resulted in a 4 fold increase of secreted IL-2 in 
the ScshRNA control relative to CD3/CD28 stimulation while the GPAMKD showed nearly a 20 
fold increase. Stimulation with CD3 alone resulted in similar amounts of IL-2 secretion between 
the GPAMKD and ScshRNA control although notably less IL-2 when compared to CD3/CD28 
costimulation.  
Based on our previous observations that phospholipid mass is decreased in primary T 
cells from the GPAT 
-/-
 mouse we predicted that GPAM may similarly regulate phospholipid 
mass in Jurkat T cells. Total lipids were extracted from GPAMKD and ScshRNA control cells 
and phosphorous assay was performed to determine the mass and mole percentage of Ptd2Gro 
(cardiolipin), PtdOh (phosphatidic acid) EtnGpl (phosphatidylethanolamine), PtdIns 
(phosphatidylinositol), PtdSer (phosphatidylserine), ChoGpl (phosphatidylcholine), CerPCho 
(sphingomyelin), and LysoPtdCho (lysophosphatidylcholine) (Table 2.1). Ptd2Gro, EtnGpl, 
PtdIns, and LysoPtdCho mass were not significantly altered in GPAMKD cells relative to the 
ScshRNA control. PtdSer mass was on average decreased in GPAMKD cells while ChoGPl mass 
was greater compared to ScshRNA control cells, although not significantly (P=.053, and P=.055 
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respectively). PtdOH, the closest direct downstream product of GPAM and CerPCho a key 
component of lipid raft microdomains were significantly decreased in GPAMKD T cells.  
Due to the critical role of phosphatidic acid in T cell signaling 
93
,
94
 and as a substrate for 
further GPL biosynthesis we hypothesized that the reduced PA mass of GPAMKD T cells may 
be a major contributing factor to their dysfunction and that introduction of exogenous PA may 
rescue the IL-2 deficient phenotype. Lipid micelles of dioleoyl (18:1) and dilauroyl (12:0) PA 
were generated and added to cultures of GPAMKD and ScshRNA cells followed by 
measurement of secreted IL-2. Addition of exogenous PA to cell cultures had a generally 
negative effect on IL-2 secretion uniformly across all samples and conditions examined (Fig. 
2.5). Most importantly, the addition of PA did not appear to increase IL-2 secretion in the 
GPAMKD under any conditions tested. The effects of PA addition appeared to be modestly 
influenced by dosage with less IL-2 inhibition observed at lower PA concentrations (data not 
shown).  
Co stimulation of Jurkat T cells with CD3 and CD28 antibody results in the rapid 
recruitment and phosphorylation of a number of key signal transduction effectors including Zap-
70 
91
. Changes in membrane phospholipid composition have been reported to disrupt signaling 
from lipid raft based receptor complexes 
95
,
96
 . Our observation that overall phospholipid mass is 
decreased in GPAMKD T cells led us to hypothesize that these changes may be interfering with 
T cell receptor (TCR) activation and subsequent phosphorylation of Zap-70, one of the earliest 
events in the IL-2 signal transduction pathway. A ~50% decrease in phospho Zap-70 (Y319) was 
observed in stimulated GPAMKD cells compared to ScshRNA controls. Stimulated GPAMKD 
cells showed a ~25% increase in Zap-70 phosphorylation compared to their unstimulated 
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counterparts while stimulation induced a ~55% increase in ScshRNA cells compared to their 
unstimulated cells (Fig. 2.6).  
 
2.5 Discussion 
We have previously demonstrated that GPAT-1 plays a key role in regulating murine T 
cell cytokine production, subset polarization, and proliferation 
7
. That data was obtained using 
primary T cells isolated from GPAT-1 knockout mice. One question that often arises when 
experimenting with specific subsets of cells from knockout animals is to what extent 
developmental or peripheral processes influence the phenotypic anomaly in question. To address 
this, we used a lentiviral delivered shRNA strategy to knock down GPAM expression in Jurkat T 
cells.  With this approach, we were able to achieve a 60% reduction in GPAM protein 
maintained stably in culture. We next sought to determine whether our GPAMKD line 
recapitulated key aspects of the murine GPAT KO T cell phenotype with regards to proliferation, 
apoptosis, and phospholipid composition.  
Primary T cells from GPAT KO mice show reduced proliferative capacity at 20 hours by 
MTT assay, while no difference is evident at 24 hours compared to WT controls 
7
. We show here 
that GPAMKD Jurkat T cells do not appear to have a proliferative defect relative to ScshRNA 
control cells and in one instance (ScshRNA stimulated vs. GPAMKD unstimulated), actually 
showed a modestly significant increase in BrdU incorporation. There are several feasible 
explanations for this disparity. One possibility is that Jurkat T cells are simply more resilient to 
the effects of GPAM deficiency than primary T cells in terms of proliferative capacity. Immortal 
cell lines such as Jurkat may have compensatory mechanisms by which to overcome alterations 
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in glycerolipid metabolism. Further experiments are needed to determine whether this is the case 
here. Another possibility has to do with the fact that there is a fundamental difference between 
what the two assays measure and the data cannot be interpreted on the same grounds. MTT and 
BrdU incorporation measure two different indicators of cellular health: metabolic activity and 
DNA replication, respectively. Further proliferation experiments in primary murine T cells by 
our group have revealed no significant difference in BrdU incorporation between T cells from 
WT and GPAT KO mice (data not shown).  
Following antigenic stimulation T cells are triggered to rapidly proliferate and expand to 
combat infectious microorganisms. This rapid expansion is usually followed by a reprogramming 
of these T cells clones with a select few becoming memory cells and the rest succumbing to 
apoptosis 
97
,
98
. Very precise molecular mechanisms have evolved to control this expansion-
deletion dichotomy so as to prevent autoimmunity and tissue damage due to long term 
occupation by cytotoxic T cell subsets. However, improper or early induction of apoptosis can 
actually hamper a proper immune response and leave an organism susceptible to infection.  
Karlsson, et. al. showed that infection of GPAT-1 KO mice with coxsackievirus B3 resulted in 
significantly increased mortality and significantly higher liver and heart viral titers compared to 
WT infected mice 
8
. This strongly suggests that GPAT-1 is necessary for mounting a proper 
immune response. We have previously demonstrated that T cells from GPAT-1 KO mice are 
highly prone to apoptosis following stimulation with CD3 and CD28 antibodies. We similarly 
show here that GPAM knock down in Jurkat T cells significantly increases the occurrence of 
apoptosis in cultured cells under both stimulated and unstimulated conditions. This is very 
intriguing as GPAM deficiency does not appear to alter proliferative tendencies. This result is 
however not without precedent as Hammond et. al. have demonstrated similar phenomena; 
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increased apoptosis balanced by increased proliferation in hepatocytes from GPAT-1 KO mice 
14
. Findings in that paper suggested that radical oxygen species (ROS) generated as a result of 
increased lipid oxidation may be responsible for increased occurrence of apoptosis in GPAT-1 
KO hepatocytes, however no direct link between ROS and DNA damage was observed nor was 
elevated active caspase 3 detected. It has been suggested that GPAT-1 plays a central role in the 
regulation of metabolic processes by competing with CPT-1 on the mitochondrial membrane for 
fatty acyl CoA substrate 
99
. We have recently shown that CPT-1 protein is significantly elevated 
in thymocytes from young GPAT KO mice which may indicate that lipid oxidation is favored 
over glycolytic energy production. In the context of T cells, this is an important observation as 
the classic paradigm is that T cells become glucose addicted following stimulation and shifting 
energy production toward lipid oxidation can induce dramatic changes in cytokine production 
and T cell phenotype. Mitochondria isolated from livers of GPAT-1 KO mice are reported to 
have an increased sensitivity to Ca
2+
 induced opening of the mitochondrial permeability 
transition pore (MPT). Increased levels of cytosolic Ca
2+
 can aid in the opening of the 
permeability transition pore which is thought to play a key role in mitochondrial mediated 
apoptosis by inducing a loss of mitochondrial membrane potential and leakage of pro apoptotic 
components such as cytochrome c and procaspases into the cytosol. The observation that 
elevated Ca
2+
 induces MPT formation at lower concentrations in the absence of GPAT-1 is very 
important in the context of the T cell. Stimulation of T cells with CD3/CD28 antibodies results in 
the activation of PLCγ, subsequent generation of IP3 and Ca2+ release from the ER. Ca2+ release 
is a critical event during T cell activation as it is necessary for Calm induced activation of the 
transcription factor NFAT, which regulates IL-2 gene expression. In T cells then, there is an 
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inherent mechanism by which cytosolic increases in Ca
2+ 
could physiologically contribute to 
MPT opening and subsequent apoptotic processes.  
IL-2 is a key cytokine produced primarily by the Th1 T cell subset that is necessary for 
the maturation of CD4+ and CD8+ effector T cells and serves to sustain an immune response by 
reinforcing pro proliferative pathways in many subsets.  Activation of the TCR-CD3 complex 
followed by coactivation of CD28 via APC presented antigen and CD80/86 respectively, 
comprise the canonical Signal 1 and Signal 2 in the activation of naïve Th cells 
100
. These events 
result in a signal transduction cascade ultimately resulting in the activation of mitogenic factors 
involved in proliferation and activation of genes encoding cytokines critical in regulating the 
immune response. Primary targets of the signal transduction pathways activated following 
engagement of the TCR/CD3 and CD28 signaling complexes are the IL-2 locus and genes 
encoding the IL-2 receptor subunits. Secreted IL-2 can then act locally through paracrine and 
autocrine signaling to activate other T cells or reinforce signaling through the IL-2 receptor 
complex by activating MAP kinase, PI3 kinase, and JAK-STAT pathways involved in 
proliferation and survival. We have previously demonstrated that splenic T cells isolated from 
GPAT KO mice produce less IL-2 when stimulated with CD3/CD28 antibodies than WT control 
mice. We show here that Jurkat T cells deficient in GPAM secrete ~40 fold less IL-2 in response 
to CD3/CD28 stimulation than their ScshRNA counterparts. Stimulation of primary T cells from 
GPAT-1 KO mice with the diacylglycerol mimic phorbol 12-myristate 13-acetate (PMA) and 
calcium ionophore, ionomycin, resulted in no significant decrease in IL-2 secretion compared to 
WT controls suggesting that the defect responsible for reduced IL-2 output in GPAT-1 deficient 
cells results from insufficient signaling or activation of the TCR-CD3 or CD28 signaling 
complex.  When we stimulated GPAMKD Jurkat T cells with PMA/ionomycin we observed a 
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~20 fold increase in IL-2 secretion compared to CD3/CD28 stimulation while ScshRNA cells 
only showed a ~6 fold increase. This data suggests that PMA/ionomycin partially rescues IL-2 
production in GPAM deficient Jurkat T cells and supports our hypothesis of a defect in 
membrane based signaling. However, there is still some issue as to why we do not observe a 
complete rescue of IL-2 output as observed in primary T cells. Further experiments possibly 
looking at the role of signaling through the IL-2 receptor or regulation of the IL-2 receptor 
subunits are needed to more thoroughly examine these phenomena. According to the membrane 
gate theory of aging, cell membranes become more rigid and lose fluidity with age 
10
. This loss 
in membrane fluidity is thought to perturb signal transduction through membrane activated 
receptors. This hypothesis is has gained special attention in the aging immunology field as a key 
characteristic of aged T cells is reduced IL-2 output and proliferative capacity. We have 
previously shown GPAT-1 activity in aged rats is significantly reduced in response to 
stimulation 
9
 suggesting that decreased GPAT-1 activity with age may contribute to a loss in 
membrane fluidity. Stimulation with CD3 alone results in modest amounts of IL-2 production 
and secretion by T cells. Co stimulation with CD28 antibody is needed to provide “signal 2” and 
fully engage signaling pathways that drive expansion processes and cytokine production. The 
CD28 receptor is localized to lipid raft microdomains and plays a key role in recruiting Lck 
tyrosine kinase and other lipid raft localized factors to the immunological synapse, a key event in 
T cell activation and induction of signaling pathways involved in IL-2 production 
67
,
34
,
101
.  If 
GPAM deficiency alters membrane fluidity it is possible that lipid raft dynamics may also be 
perturbed and that CD28 dependent raft recruitment and localization is dysfunctional, thereby 
hampering the co stimulatory signal. To test this hypothesis in GPAMKD and ScshRNA Jurkat T 
cells we stimulated with CD3 or CD28 alone and found that IL-2 secretion was unaltered in 
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GPAMKD Jurkat cells. One interpretation of this data is that TCR-CD3 based signaling alone 
and C28 signaling alone are intact when stimulated independently of each other and GPAM 
deficiency leads to a loss of the CD3/CD28 co stimulatory signal. This data therefore suggests 
that GPAM regulates IL-2 production in Jurkat T cells by interfering with co stimulatory signals 
necessary for full induction of IL-2 expression through a mechanism possibly involving 
perturbation of membrane fluid dynamics.  
The direct downstream product of GPAT-1 is lysophosphatidic acid which can be further 
acylated to phosphatidic acid by AGPAT enzymes on the endoplasmic reticulum.  The exact 
contribution of GPAT-1 to the generation of triglyceride and glycerophospholipid is not 
completely known but several studies have indicated that it may vary depending on tissue and 
cell type 
89
. Glycerophospholipids play a key role in the regulation of membrane fluid dynamics 
and it is possible that loss of GPAT activity with age contributes to reduced membrane fluidity 
by reducing gycerophospholipid output. It is interesting then that primary T cells from GPAT-1 
KO mice have significantly decreased membrane glycerophospholipid compared to their WT 
counterparts. The most striking decrease however was observed in phosphatidic acid, the 
precursor of all glycerophospholipids which suggested that in T cells, GPAT-1 is a principle 
contributor to the phosphatidic acid pool and may play an essential role in providing PA for the 
bulk production of all glycerophospholipid. Phosphlipid mass analysis in GPAMKD Jurkat T 
cells revealed significant decreases in phosphatidic acid and sphingomyelin. However, other 
phospholipid levels remained unaltered. Sphingomyelin is a key component of lipid rafts and is 
thought to contribute to their structure through interaction with cholesterol in the cell membrane. 
Decreased sphingomyelin could interfere with lipid raft dependent signal transduction such as in 
the case of TCR based activation. The decrease in phosphatidic acid observed first in primary T 
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cells and then in GPAMKD Jurkat cells led us to hypothesize that T cell dysfunction observed in 
old and GPAT-1 KO cells may be due to decreases in the cellular phosphatidic acid pool. Until 
very recently it was thought that Ras directly recruited the serine/threonine kinase Raf-1 to the 
cell membrane, however a seminal study by Rizzo, et. al. showed for the first time that Raf-1, an 
essential component of the MAPK signaling cascade physically binds PA in order to localize to 
membranes and this binding is independent of Ras association 
102
. In fact, it is PA dependent 
membrane association of Raf-1 that actually activates its kinase activity through a poorly 
understood mechanism involving Ras. Further studies showed that mutation of PA binding 
domains in Ras completely abrogates Raf-1 dependent MAPK signaling and results in cell cycle 
arrest 
103
. Once activated Raf-1 can phophorylate and activate MEK, a tyrosine/threonine kinase 
which can go on to phosphorylate and activate the pluripotent serine/threonine kinases Erk 1 and 
Erk 2. The Erk family is directly involved with transcription factor activation in the nucleus, and 
in the case of T cells drive the expression of IL-2 through NFAT, AP-1, and NF-κB transcription 
factors. Previous work probing PA mediated MAP kinase signaling in T cells has focused on two 
mechanisms of PA production;  (i)PLD mediated hydrolysis of phosphatidylcholine and (ii) 
phosphorylation of diacylglycerol by DAGK-α . The predominant opinion in the literature is that 
PLD2 and DAGK-α are the principle contributors of PA in TCR based signal transduction 
cascades 
94
. We hypothesized that GPAM may be a significant contributor to the phsophatidic 
acid pool and in its absence; PLD2 and DAGK may be incapable of overcoming this sink and 
thusly hindering T cell activation. To test this hypothesis we attempted to rescue IL-2 production 
in GPAMKD Jurkat T cells by the addition of exogenous PA to culture. We used two types of 
PA, 12:0 which has been reported in the literature to have a mitogenic effect on T cells and 18:1 
which is more physiologically relevant in terms of PA found in most cells types. We did not 
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observe any increase in IL-2 production with PA addition under any of the conditions tested. In 
fact, we report here an inhibitory effect of PA addition under stimulated and unstimulated 
conditions. It is possible that the PA contributed by GPAM is actually serving as precursor for 
further GPL biosynthesis and not in the capacity of a signaling or anchoring molecule itself. It is 
likely that the time points we examined of 6 and 24 hours were insufficient to allow for global 
membrane remodeling. Taking this experiment out to further time points creates a challenge as 
lipid toxicity becomes an issue as more PA is added to culture. Another possibility is that PA is 
not suitably available biologically in the free and micelle form which we added it to culture. 
Dose responses revealed that concentration did play a role in the reduction of IL-2 production 
(data not shown) albeit modestly. At concentrations of 10 μM PA of both types in micelle form 
resulted in a nearly identical proportional decrease in IL-2 output under all conditions tested in 
both GPAMKD and ScshRNA control cells suggesting that this phenomenon was independent of 
GPAM. Further elucidation of the role of GPAM generated PA in activation of mitogenic 
signaling and contribution to GPL synthesis is needed before its role is completely dismissed.  
Successful TCR engagement results in phosphorylation of ITAM motifs on CD3-ζ 
subunits initiated by Lck and Fyn which associate with the cytosolic tails of the CD4 and CD8 
co-receptors on helper and cytotoxic T cells. Activated Lck can phosphorylate tyrosine residues 
on CD3-ζ subunits which can then serve as a recruitment site for the tyrosine kinase ZAP-70. 
ZAP-70 binds and engages the dual phosphorylated ITAMs on the CD3-ζ chain via its tandem 
SH-2 domains allowing for Lck mediated phosphorylation and activation of  ZAP-70. This puts 
ZAP-70 in a position to phosphorylate the transmembrane adaptor protein; LAT.  
Phosphorylated LAT in turn serves as a docking site for a myriad of SH2 domain containing 
signaling proteins.  If deficiencies in GPAM generated GPL are responsible for perturbations in 
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membrane based signaling we hypothesized that very early events in TCR activation following 
CD3/CD28 stimulation may be disrupted. To test this hypothesis we stimulated GPAMKD and 
ScshRNA cells and measured the relative amounts of phospho ZAP-70 (Y319) by ELISA, an 
indicator of successful Lck mediated phosphorylation and successful TCR-CD3 and CD28 
activation. We observed a significant decrease in the amount of phospho ZAP-70 (Y319) in 
GPAMKD Jurkat cells compared to ScshRNA control cells. This data strongly suggests that 
GPAM regulates IL-2 production in Jurkat T cells through a mechanism dependent on very early 
signal transduction events following stimulation. Based on the observation that CD3 stimulation 
yielded equal IL-2 output in GPAMKD and ScshRNA cells, we propose that decreased IL-2 
production in the absence of GPAM may be at least partially attributed to a failure in the 
recruitment of key raft components to the immunological synapse to provide signal 2. Lck is 
thought to autophosphorylate following T cell activation. The precise mechanisms involved in 
Lck activation are still under investigation although evidence has been presented that support a 
role for CD4 and CD28 induction and maintenance of Lck phosphorylation. It has also been 
proposed that CD28 and lipid rafts coordinate the recruitment of Lck to the immunological 
synapse 
67
. Further experiments to determine the localization of Lck to the immunological 
synapse are needed to verify that GPAM regulates IL-2 production in Jurkat T cells by altering 
membrane phospholipid in such a way as to interfere with CD28 costimulation.  
We have for the first time shown here that the human homologue of GPAT-1, GPAM 
plays an important role in stimulation induced IL-2 production and T cell fate. Additionally, we 
demonstrate that GPAM deficiency itself plays a key role in T cell dysfunction outside of the 
context of an animal model. Our data suggest that GPAM regulates IL-2 production through 
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altering membrane phospholipids in such a way as to alter proper T cell activation and that this 
process results in increased apoptosis and cell death.  
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Figure 2.1 Quantitative RT PCR for GPAM transcript. 
 
 
Figure 2.1.  mRNA was isolated from ScshRNA and GPAMKD Jurkat T cells and quantitative 
reverse transcriptase PCR was performed to determine GPAM gene expression. Results were 
normalized to GAPDH.   
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Figure 2.2 GPAM Western Blot and Densitometry 
 
 
 
Figure 2.2.  a). GPAM Western blot in ScshRNA and GPAMKD Jurkat T cells. b). Densitometry 
was performed to normalize relative amount of GPAM protein present against Actin loading 
control.  
 
 
 
 
 
 
  
 
 
 
 
 
GPAMKD ScshRNA 
a) b) 
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Figure 2.3 BrdU Proliferation and Apoptosis in GPAMKD and ScshRNA Jurkat T cells 
 
 
Figure 2.3 a). BrdU proliferation assay in GPAMKD and ScshRNA Jurkat T cells. T cells were 
stimulated or not with CD3/CD28 antibody for 24 hours in the presence of BrdU and 
subsequently stained with fluorophore conjugated BrdU antibody and fluorescence was read on 
an Accuri C6 flow cytometer. b). T cells were stimulated or not with CD3/CD28 antibody for 24 
hours and apoptotic and dead cells were determined as described in materials and methods. 
Significance (p>0.05) is indicated with an asterisk.  Each assay was carried out in sextuplet. 
Significance was determined using one-way ANOVA and post-hoc analysis carried out with 
Tukey’s multi-comparison test (P>0.05). 
 
 
 
 
 
 
 
 
 
 
a) b) 
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Figure 2.4 IL-2 Production at 24 hours and CD3 only Stimulation 
 
 
Figure 2.4 a). IL-2 secretion by ScshRNA and GPAMKD Jurkat T cells at 24 hours. T cells were 
stimulated or not with CD3/CD28 antibody or PMA/Ionomycin for 24 hours or 6 hours (b) and 
IL-2 secretion was determined by ELISA. c). T cells were stimulated or not with CD3 or CD28 
antibody alone for 24 hours and IL-2 secretion was determined by ELISA. Each assay was 
carried out in sextuplet. Significance was determined using one-way ANOVA and post-hoc 
analysis carried out with Tukey’s multi-comparison test (P>0.05). 
 
 
 
 
 
b) a) 
c) 
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Table 2.1. Phospholipid Mass and Mole % in ScshRNA and GPAMKD Jurkat T cells 
 
Mole % ScshRNA GPAMKD 
  
 
AVG STD AVG STD 
 
P value sig? 
Ptd2Gro 2.20 0.257 2.06 0.231 
 
0.344 ns 
PtdOH 2.79 1.368 1.94 0.613 
 
0.195 ns 
EtnGpl 17.74 2.213 16.03 3.253 
 
0.312 ns 
PtdIns 3.30 1.338 3.44 1.343 
 
0.860 ns 
PtdSer 4.23 1.293 3.05 0.863 
 
0.093 ns 
ChoGpl 58.84 4.144 64.66 3.603 
 
0.027 sig 
CerPCho 6.13 0.349 4.18 1.515 
 
0.012 sig 
LysoPtdCho 3.74 1.249 3.52 1.164 
 
0.759 ns 
        Mass ScshRNA GPAMKD 
  
 
AVG STD AVG STD 
 
P value sig? 
Ptd2Gro 4.05 0.526 3.66 0.218 
 
0.124 ns 
PtdOH 5.24 2.753 3.52 1.365 
 
0.200 ns 
EtnGpl 32.65 3.947 28.22 3.494 
 
0.067 nqs 
PtdIns 6.18 2.725 6.28 2.851 
 
0.952 ns 
PtdSer 7.88 2.708 5.47 1.807 
 
0.100 nqs 
ChoGpl 108.49 9.138 115.84 16.206 
 
0.356 ns 
CerPCho 11.28 0.450 7.51 2.712 
 
0.007 sig 
LysoPtdCho 6.83 2.040 6.14 1.598 
 
0.693 ns 
 
Table 2.1 Total lipids were extracted from ScshRNA and GPAMKD Jurkat T cells and separated 
via TLC. Phospholipid mass was determined by phosphorous assay. Averages (AVG) respresent 
3 independent cultures. Significance (P>0.05) was determined by 2 tailed students T test. 
Significantly different is indicated by “sig” and not significant “ns”.  
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Figure 2.5 The Effect of Phosphatidic Acid (Micelle) Addittion on IL-2 Production in 
GPAMKD and ScShRNA Jurkat T Cells During 24 Hour Stimulatory Period 
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Figure 2.5. PA lipid micelles were made as described and added to cultures of ScshRNA or 
GPAMKD Jurkat T cells under stimulated (CD3/CD28) or unstimulated conditions and cultured 
for 24 hours. IL-2 secretion was then measured by ELISA. Each assay was carried out in 
sextuplet. Significance was determined using one-way ANOVA and post-hoc analysis carried 
out with Tukey’s multi-comparison test (P>0.05). 
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Figure 2.6 Zap-70 Phosphorylation 
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Figure 2.6. ScshRNA and GPAMKD Jurkat T cells were stimulated with soluble CD3/CD28 and 
rapidly lysed. Phospho Zap-70 was detected and quantified via ELISA. Each assay was carried 
out in sextuplet. Significance was determined using one-way ANOVA and post-hoc analysis 
carried out with Tukey’s multi-comparison test (P>0.05).  
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Chapter 3 
Glycerol-3-Phosphate Acyltransferase Is Necessary for Activation of the Stimulation 
Induced Metabolic Switch in Murine CD4
+
 T cells 
 
3.1 Abstract 
Glycerol-3-phosphate acyltransferase-1 is the first and rate limiting step in de novo 
glycerophospholipid synthesis. We have previously demonstrated that GPAT-1 regulates murine 
T cell function. The resultant phenotype is characterized by decreased IL-2 production, increased 
propensity toward apoptosis, and altered membrane glycerophospholipid mass similar to that of 
an old T cell. Recent studies have suggested that changes in the metabolic profile of T cells are 
responsible for defining specific effector functions and T cell subsets. So we asked the question 
as to whether our previous observations regarding T cell dysfunction in GPAT-1 
-/-
 T cells could 
possibly be explained by changes in cellular metabolism. We show here for the first time that 
GPAT-1 
-/-
 T cells suffer from several key metabolic defects likely contributing to their 
dysfunctional phenotype. First, we observed a significant reduction in mitochondrial mass in 
GPAT-1 
-/-
 T cells compared to their WT counterparts indicating that GPAT-1 deficiency results 
in either fewer or smaller mitochondria. We next identified striking decreases in both the oxygen 
consumption rate (OCR) and the extracellular acidification rate (ECAR) of GPAT-1 
-/-
 T cells 
following CD3/CD28 stimulation indicating an inherent cellular defect in energy production. 
These differences were observed throughout a series of mitochondrial stress tests using 
oligomycin, FCCP, and rotenone to detect OCR under coupled, uncoupled and non-
mitochondrial respiration respectively. Treatment with FCCP and subsequent subtraction from 
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basal readings allowed us to calculate the spare respiratory capacity (SRC) of GPAT-1 
-/-
 T cells, 
a key indicator of the cells ability to cope with mitochondrial stress. We found that the 
proportional decreases in the metabolic profile observed basally and in the presence of inhibitors 
were underscored by an inherent mitochondrial defect as evidenced by significantly decreased 
SRC in in GPAT-1 
-/-
 T cells. These data demonstrate that deletion of  GPAT-1 has deleterious 
effects on total cellular metabolism under conditions of increased energy need. Furthermore, 
altered metabolic response following stimulation may be the defining mechanism underlying T 
cell dysfunction in GPAT-1 
-/-
 T cells. Taken together these results indicate that GPAT-1 is 
essential for regulation of the stimulation induced metabolic switch in T cells.  
 
3.2 Introduction 
Glycerol 3-phosphate acyl transferase-1 [GPAT-1] is an integral mitochondrial 
membrane protein responsible for conjugating fatty acyl-CoA with glycerol-3 phosphate in the 
first and rate limiting step of de novo glycerophospholipids synthesis
104
. GPAT-1 catalyzes the 
conversion of glycerol-3 phosphate and acyl-CoA to lyosphosphatidic acid (LPA) which is then 
further acylated to phosphatidic acid which serves as a precursor for all glycerophospholipid 
(GPL) and triglyceride synthesis. Fatty acids are activated to acyl-CoAs on the outer 
mitochondrial membrane before entering either the glycerolipid biosynthetic pathway via GPAT-
1 or the β-oxidation pathway via carnitine palmitoyltransferase-1 (CPT1) which is thought to 
compete with GPAT-1 for fatty acyl co-A substrate at the outer mitochondrial membrane. Both 
CPT-1 and GPAT-1 are sensitive to nutrient levels within the cell, specifically the ATP/AMP 
ratio. AMP activated protein kinase (AMPK) activity increases when there is an abundance of 
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AMP within the cell, signaling that ATP levels are low. Consequently, activated AMPK 
regulates both CPT-1 and GPAT-1 reciprocally. When cellular energy stores are low AMPK is 
activated and downregulates GPAT-1 activity, while promoting CPT-1 activity. We have 
previously shown that GPAT-1 activity is upregulated following stimulation by T cell specific 
protein kinase c theta (PKCθ) 27. Interestingly, we also found that stimulation induced 
upregulation of GPAT-1 activity is significantly blunted in old T cells, suggesting that T cell 
dysfunction with age may be at least partly attributed to altered cellular GPL levels. 
T cells from GPAT-1 
-/-
 mice share many characteristics with old T cells including 
increased cholesterol to glycerophospholipid proportions and reduced IL-2 production following 
stimulation 
7
.  GPAT-1 activity, but not expression is reduced in T-cells from old rats implying 
that age related decline in GPAT-1 activity may be a primary contributor to immunosenesence 
through a mechanism modulated by alterations in glycerophospholipid 
9
. Decreased GPL to 
cholesterol ratios are thought to be a principle contributor to decreased membrane based signal 
transduction in senescent cells as described by the “membrane gate” theory of aging 10. 
Interestingly, we have also shown that GPAT-1
-/-
 T cells secrete increased levels of IL-17 
105
, a 
proinflammatory cytokine associated with increased autoimmunity in aging and have elevated 
levels of CD4
+
CD25
+
FoxP3
+
  T cells (Treg) (unpublished observation) also observed in aging 
12
,
106
. Elevated IL-17 secretion in combination with elevated Treg is highly significant as it has 
been demonstrated that in the absence of TGF-β Treg are capable of polarizing CD4+ T cells 
toward a Th17 phenotype 
107
.   
Quiescent T cells must rapidly upregulate modes of energy production in response to 
stimulation by cognate antigen to drive clonal expansion and cytokine production. T cell 
metabolism is emerging as a key regulator of the type and extent of an immune response. 
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Canonically, it is thought that this process primarily engages glycolytic pathways of energy 
production. However, evidence is emerging that the preferred energy substrate depends on the T 
cell subset in question. It was recently shown that Treg subsets for example, have a metabolic 
preference for lipid oxidation while Th1 and Th2 subsets rely heavily on glycolysis and Th17 
subsets engage both lipid and glycolytic pathways 
4
. In that study it was also shown that 
rapamycin treatment or fatty acid addition alone enhanced Treg differentiation while blockade of 
lipid oxidation via etomoxir prevented Treg generation 
4
. In another interesting study, CD8+ 
memory T cells have recently been shown to possess substantially more spare respiratory 
capacity than CD8+ T effector cells which confers the ability to handle increased stress and 
promote long term survival, possibly 
76
.  
Aged T cells are more susceptible to the damaging effects of oxidative stress which has 
been linked to sensitization of the mitochondria and reduced spare respiratory capacity 
108
. 
Increased oxidative stress is thought to contribute significantly to mitochondrial DNA mutations 
with age and has been suggested to play a role in degenerative disease and cancer development 
109
. This is significant in the context of GPAT-1 for three key reasons. First, GPAT-1 is an 
integral mitochondrial membrane protein and its activity may serve to locally supply the 
mitochondria with lysophosphatidic acid for glycerophospholipid synthesis. Therefore, loss of 
GPAT-1 may structurally alter mitochondrial integrity and compromise mitochondrial membrane 
potential resulting in T cell unresponsiveness. We have previously shown that the exclusive 
mitochondrial membrane lipid; cardiolipin is decreased in T-cells of Gpat-1 
-/-
 mice in addition 
to a global decrease in most major GPL 
7
. Second, we have demonstrated that Gpat-1 
-/-
 T-cells 
are more prone to an “apoptosis like” program of cell death following stimulation and 
proliferation appears to be reduced as assessed by MTT assay 
7
. These observations are 
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supported by work from Rosalind Coleman’s lab with Gpat-1 -/- hepatocytes, where similar 
stimulation induced cell death was observed 
14
. Third, that mitochondria from Gpat-1 
-/-
 
hepatocytes lose mitochondrial outer membrane potential (MOMP) rapidly and form extensive 
mitochondrial permeability transition pores (MPTP) in response to addition of exogenous Ca
2+ 
 
suggests that GPAT-1 plays a critical role in regulating mitochondrial integrity
14
. It is also very 
interesting then that MPTP formation is significantly increased following TCR stimulation in old 
murine T-cells 
110
 . These observations construct a scenario in which stimulation of the T cell 
increases intracellular Ca
2+
 levels inducing MPTP formation and subsequent loss of MOMP.  
Since both GPAT-1 activity and cardiolipin content are reduced with ageing, this mechanism 
may be a major contributing factor to immunosenescence. 
In the current study we sought to determine how GPAT-1 deficiency alters CD4
+ 
T cell 
metabolism and whether these changes may underlie T cell dysfunction. We found a small 
although significant difference in mitotracker staining suggesting either fewer or smaller 
mitochondria in the GPAT-1 KO mouse in addition to only a modest decrease in proliferative 
capacity as assessed by BrdU incorporation suggesting that decrease proliferation observed by 
MTT assay are actually more indicative of loss a loss in mitochondrial redox capacity. 
Unstimulated GPAT-1 KO T cells appear to be metabolically equivalent to their WT 
counterparts. However, stimulation revealed gross deficiencies in both respiratory and glycolytic 
metabolism in GPAT-1 KO T cells. We also observed significantly reduce spare respiratory 
capacity, an indicator of the cells ability to cope with mitochondrial stress, in GPAT-1 KO T 
cells. These findings suggest that T cells deficient in GPAT-1 are unable to meet the high energy 
demands concomitant with stimulation and shift their available metabolic resources into cell 
survival.  
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3.3 Materials and Methods 
Mice and T cell Isolation/stimulation 
Male C57BL/6 GPAT-1 KO mice were obtained from Dr. Rosalind Coleman (University 
of North Carolina at Chapel hill and bred in our animal facilities. Age matched male C57BL/6 
mice were obtained from Charles River. At 5 months of age mice were sacrificed and spleens 
taken. Spleens were gently homogenized and single cell suspensions obtained. Cell suspensions 
were stained with Miltenyi anti CD4 (L3T4) coated microbeads and magnetically separated by 
passing them through a Miltenyi LS column within a magnetic field. Non labeled cells were 
washed through the column and CD4+ T cells were collcted by removing the column from the 
magnetic field and forcing 5 mL of buffer through the column with a plunger. Typically, 1.3-
1.5X10
7
 CD4
+
 T cells were obtained from each mouse. These numbers did not significantly 
differ between WT and GPAT-1 KO mice. Freshly isolated CD4+ T-cells were plated at a 
density of 3X10
6
 cells/mL and stimulated at 37°C for 20 hours in complete RPMI 1640 culture 
media (10% heat-inactivated fetal bovine serum plus 100 U/ml penicillin, 100 µg/ml 
streptomycin, 10 µM β-mercaptoethanol, and 100 mM L-glutamine) and stimulated with 10 
µg/ml plate-bound anti-CD3 and 1 µg/ml soluble anti-CD28 or left unstimulated. 
 
Mitochondrial Quantitation 
Freshly isolated T cells were incubated at 37C with 100 nM Mitotracker for 30 minutes. 
Cells were then washed twice and then resuspended in 1 mL of PBS. Cells were then analyzed 
on the Accuri C6 Flow cytometer and analysis carried out with Accuri C6 software.   
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BrdU Incorporation and CD4 staining 
T cells were isolated and pooled from 10 WT or 10 GPAT-1 KO mice. Proliferation was 
measured using the BD biosciences APC BrdU Flow Kit. For stimulated conditions, 96 well 
plates were coated with 10 µg/ml of CD3 antibody in NaHCO3 buffer and incubated for 4 hours 
at 37°C. Then 1 mM BrdU diluted in PBS and 1 μg/mL of CD28 antibody was added to cultures 
in complete media at a density of 10
6
 cells/mL and incubated at 37°C for 20 hours. For 
unstimulated conditions, non CD3 coated plates were used and CD28 antibody was not added. 
Following incubation cells were fixed and permeabilized according to the manufacturer’s 
protocol and APC fluorescence was measured by flow cytometry on an Accuri C6 flow 
cytometer.  
 
Protocol Optimization for Seahorse Extracellular Flux Analyzer 
We first determined the optimal number of murine T cells needed to place oxygen 
consumption (OCR) and extracellular acidification rate (ECAR) readings in an interpretable 
range within the limitations of the Seahorse XF24 Analyzer, and at the same time provide a 
sufficient number of CD4
+
T cells for all of the assays planned. We found 500,000 murine T cells 
were sufficient to accomplish these ends. We next sought to determine optimal concentrations of 
the mitochondrial inhibitors oligomycin, Carbonyl cyanide-4-(trifluoromethoxy) 
phenylhydrazone (FCCP), and rotenone. Dosage response analysis with various inhibitor 
concentrations revealed the optimal combination of inhibitor concentrations for our needs to be: 
2μM oligomycin, 3μM FCCP, and 4μM rotenone. Prior to each assay, inhibitors were made fresh 
from frozen stocks and aliquoted into the microinjection ports of the XF-24 flux plate. We next 
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determined the optimal palmitic acid/BSA conjugate concentration to use for the fatty acid 
oxidation assay. Concentrations of 25, 50, 100, and 200μM with the goal being to use the highest 
concentration that yielded a discernible difference in COR. We found that concentrations of 100 
and 200μM palmitic acid yielded similar increases in OCR and opted for the lower concentration 
of 100μM to use in proceeding assays. Prior to each assay, fresh palmitic acid/BSA conjugate or 
BSA only for controls, were made fresh from frozen stocks and aliquoted into the microinjection 
port of the XF-24 flux plate. 
Metabolic Profile 
T cells were isolated and cultured as previously described. After 20 hours, T cells were 
harvested and washed in 5 mL of pre-warmed Seahorse XF assay medium and resuspended to a 
concentration of 10 X 10
6
 cells/mL and 50 μL of this suspension was added to a poly-l lysine 
coated dish for a final count of 500,000 cells/well and incubated at 37°C for 30 minutes in a non-
CO2 incubator. 450μL of XF assay medium was then added to each well, the top of the plate 
containing the injection ports and probes added, and the metabolic profile read with the XF-24 
Extracellular Flux Analyzer (Seahorse Bioscience).  
 
Fatty Acid Oxidation Profile 
T cells were isolated and cultured as previously described. After 20 hours, T cells were 
harvested and washed in 5 mL of pre-warmed minimal KHB assay medium (111  mM NaCl, 4.7 
mM KCl, 2 mM MgSO4, 1.2 mM Na2HPO4, 2.5 mM glucose, and 0.5 mM carnitine) and 
resuspended to a concentration of 10 X 10
6
 cells/mL and 50 μL of this suspension was added to a 
poly-l lysine coated dish for a final count of 500,000 cells/well and incubated at 37°C for 30 
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minutes in a non-CO2 incubator. 450μL of KHB assay medium was then added to each well, the 
top of the plate containing the injection ports and probes added, and the metabolic profile read 
with the XF-24 Extracellular Flux Analyzer (Seahorse Bioscience).  
Statistical Analysis 
Statistical significance was determined using one-way analysis of variance due to the 
non-normal distribution of data. Data are considered significant from control values when P 
<0.05. Post hoc analysis was conducted using Tukey’s multiple-comparison test with GraphPad 
Prism (San Diego, CA, USA). 
 
3.4 Results  
Total mitochondrial content was quantified by mitotracker staining. GPAT-1 KO T cells 
showed a small but significant decrease in mitochondrial content compared to WT controls (Fig. 
3.1). This difference could be the result of either reduced mitochondrial number or smaller 
mitochondria.  
We have previously reported that proliferation in GPAT-1 KO T cells is significantly 
decreased at 20 hours when assessed by MTT assay. Since GPAT-1 deficiency may result in a 
loss of mitochondrial redox potential, we sought to assess proliferation by a more direct means 
such as BrdU incorporation. To control for heterogeneities that can occur with multiple T cell 
isolations and rounds of stimulation we pooled T cells from 10 WT or 10 GPAT-1 KO age 
matched mice. Total and CD4+ GPAT-1 KO T cells incorporated approximately 10% and 11% 
less BrdU than their WT counterparts respectively (Fig. 3.2). Interestingly, there appeared to be 
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no difference in BrdU incorporation between WT and GPAT-1 KO CD8+ T cells (data not 
shown). Furthermore, we previously reported that a significant difference in tetrazolium 
reduction was only observed at 20 hours and not at earlier or later time points which suggests 
that previous observations are indeed more reflective of a mitochondrial defect and not loss of 
proliferative capability 
 
Metabolic Profiles of WT and GPAT-1 KO CD4+ T cells 
CD4+ T cells were isolated and stimulated with CD3/CD28 antibodies or not for 20 
hours in complete RPMI media after which cells were harvested and plated onto poly-l lysine 
coated 24 well plates and their metabolic profiles read with the Seahorse XF analyzer. Under 
basal conditions, stimulated GPAT-1 KO T cells showed significantly less respiratory and 
glycolytic activity as determined by their respective oxygen consumption rate (OCR) and 
extracellular acidification rates (ECAR) (OCR: Fig. 3.3a ECAR: Fig. 3.5a). However, there 
appeared to be no significant difference between the metabolic profile of unstimulated GPAT-1 
KO and WT T cells (Fig 3.4). Basal readings of the OCR/ECAR ratio revealed no significant 
difference between stimulated or unstimulated WT and GPAT-1 KO T cells suggesting that 
glycolysis and OXPHOS are engaged in a proportionally equivalent manner (Fig. 3.4f). 
Injection of oligomycin, an ATP synthase inhibitor, followed by intermittent metabolic 
monitoring over a 24 minute time period revealed a proportional decrease in OCR and ECAR in 
stimulated GPAT-1 KO compared to WT controls while no significant difference was observed 
in unstimulated samples, indicating a blunted metabolic profile for the GPAT-1 KO (OCR: Fig. 
3.4b, ECAR: Fig. 3.6b) . Likewise, treatment with FCCP, an uncoupler resulted in decreased 
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maximal respiratory capacity and ECAR in stimulated GPAT-1 KO T cells, however no 
difference was observed in unstimulated controls (OCR: Fig. 3.4c, ECAR: Fig.3.6c). When 
maximal respiration was subtracted from basal respiratory levels in stimulated samples we found 
that GPAT-1 KO T cells have significantly reduced spare respiratory capacity (SRC) strongly 
implicating an inherent mitochondrial defect that may hinder their ability to upregulate energy 
production in response to stimulation (Fig. 3.4d). The SRC shows that there is something more 
than merely a proportional difference in the metabolic profile of GPAT-1 KO T cells and is 
indicative of a specific defect in the mitochondrial stress coping capability of the GPAT-1 KO. 
Treatment with rotenone shuts down electron transport and allows for the measurement of non-
mitochondrial respiration, of which we found no significant difference between GPAT-1 KO and 
WT under stimulated or unstimulated conditions, however ECAR did appear decreased in the 
stimulated GPAT-1 KO compared to the stimulated WT (OCR: Fig. 3.4d, ECAR: 3.6d). This 
data suggests that decreased oxygen consumption rates observed in the GPAT-1 KO are the 
result of an inability of these cells to upregulate mitochondrial respiratory metabolism in 
response to stimulation. It did not appear in any case that glycolytic means of energy production 
were upregulated in response to these energy deficits as determined by no compensatory increase 
in ECAR. This indicates that GPAT-1 KO T cells suffer from a severe energy deficit in response 
to stimulation which may underlie many facets of their previously reported dysfunctional 
phenotype 
7
.   
We have previously reported elevated CPT-1a protein levels in GPAT-1 KO thymocytes 
13
 so in the current study we sought to determine whether this correlated with increased lipid 
oxidative modes of energy production. Basal readings were acquired for 24 minutes followed by 
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injection of 100 μM palmitate/BSA conjugate intermittent monitoring of OCR and ECAR for 80 
minutes in WT and GPAT-1 KO T cells.  
Basal OCR and ECAR readings differed significantly between stimulated GPAT-1 KO 
and WT T cells even more so than basal levels reported for the respiratory assay (Fig. 3.7a and 
3.8a). One possible explanation for this is that the KHB formulation used for this assay is very 
minimal in regard to micronutrients (see materials and methods for composition) compared to 
the Seahorse XF media used in the respiratory assay exacerbating any underlying defects in 
metabolism. Much like the respiratory assay, we observed no significant difference in OCR or 
ECAR in unstimulated samples. Interestingly, no difference in OCR was observed between 
stimulated GPAT-1 KO and unstimulated WT controls implying that stimulation is unable to 
overcome the metabolic defect in GPAT-1 KO T cells in minimal KHB media. Following 
palmitate/BSA injection OCR readings for stimulated GPAT-1 KO T cells were significantly 
elevated compared to unstimulated samples and significantly reduced compared to WT. 
However, similar to basal readings, no significant difference was observed between stimulated 
GPAT-1 KO and unstimulated WT. ECAR readings following palmitate /BSA injection 
appeared significantly different between all samples tested. Despite increased CPT-1 protein 
levels as previously reported, there appear to be no significant increases in lipid oxidative 
metabolism in GPAT-1 KO T cells.  
Interestingly, FA/BSA injection significantly increased OCR readings in all unstimulated 
samples compared to BSA only injected unstimulated samples suggesting that the presence of 
fatty acid itself is sufficient to upregulate respiratory metabolism in resting T cells. FA/BSA 
injection also had the unexpected effect of increasing ECAR in stimulated samples while no 
effect was observed in unstimulated samples. FA/BSA injection significantly increased ECAR 
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readings in stimulated WT samples compared to BSA injected alone, while no increase was 
observed in GPAT-1 KO samples. Recently it has been demonstrated that in skeletal muscle cells 
that palmitate treatment rapidly upregulates GLUT4 expression and stimulates glucose uptake 
111
. To the best of our knowledge this is the first time that a similar phenomenon has been 
observed in primary murine T cells. 
 
3.5 Discussion 
Conventional thought is that activated T cells become heavily reliant on glycolysis 
following stimulation and switch to an “anabolic” program of metabolism that supports clonal 
expansion even in the presence of adequate oxygen to support mitochondrial oxidative 
phosphorylation (OXPHOS) 
112
,
85
. However, the exact role of mitochondrial OXPHOS during T 
cell stimulation remains unclear. Our data clearly show that stimulated T cells up regulate both 
OXPHOS and glycolysis in response to stimulation.  Furthermore, the OCR/ECAR ratio is 
significantly increased in response to stimulation demonstrating that OXPHOS is indeed 
significantly upregulated in CD4
+
 T cells while unstimulated T cells appear to rely more on 
glycolysis. Interestingly, offering palmitate as a fuel source, even in the presence of glucose, 
significantly increased mitochondrial oxygen consumption. This effect was observed in both 
stimulated and unstimulated cells. We observed no difference in the respiratory profile of 
unstimulated WT and GPAT-1 KO T cells suggesting that T cell dysfunction in the absence of 
GPAT-1 only becomes apparent under conditions of increased energy demand.  That there is no 
compensatory increase in glycolysis following any of the treatments suggests that the GPAT-1 
KO T cell is not properly responding to stimulation and thus not engaging normal modes of 
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metabolism. Furthermore, a failure to upregulate glycolysis implies that GPAT-1 
-/-
 T cells suffer 
from a severe energy sink which they may be unable to overcome a consequence of which may 
be decreased IL-2 production and decreased proliferative capability. Significant decreases in 
SRC observed in the GPAT-1 KO are indicative of an inherent defect in the mitochondrial stress 
response more so than a proportional decrease in the metabolic profile. It is therefore likely that 
GPAT-1 deficiency is pleitropic in its effects on T cell metabolic function. 
Our data demonstrate that GPAT-1 is necessary for regulating the increased energy 
demand placed on T cells following stimulation. In the absence of stimulation we saw no general 
difference in the metabolic profile of GPAT-1 KO T cells compared to their WT counterparts 
suggesting that GPAT-1 dependent lipid biosynthesis plays a critical role in regulating the 
stimulation induced metabolic switch. One possible explanation is that GPAT-1 KO T cells have 
reduced mitochondrial mass implying that either mitochondrial size or number is reduced, a 
consequence of which is decreased respiratory capability. However, it is more likely that GPAT-
1 deficiency results in smaller, compromised mitochondria rather than physically fewer 
mitochondria in light of observations in the liver showing increased susceptibility to Ca
2+
 
induced opening of the MPTP 
14
. This is intriguing in context of the T cell as substantial 
increases in intracellular Ca
2+
 are necessary for activation of critical factors responsible for 
driving cytokine production and pro proliferative signaling. This presents the possibility that 
GPAT-1 plays a critical role in maintaining mitochondrial integrity, most likely by providing a 
source of GPL for mitochondrial membranes. Another possibility is that GPAT-1 KO T cells are 
less responsive to CD3 stimulation similar to old T cells 
113
. Changes in membrane phospholipid 
ratios are thought to interfere with proper activation of membrane based signaling complexes 
with age
10
. It is interesting then, like old T cells, GPAT-1 KO T cells have significantly reduced 
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levels of nearly all of the major GPLs and analysis of molar lipid mass per cell makes it unlikely 
that this reduction in GPL is solely due to altered mitochondrial membrane composition. Instead, 
it is more probable that GPAT-1 deficiency results in decreased GPL mass in all cellular 
membranes. Defects in cellular membranes are capable of interfering with membrane based 
signal transduction such as that required during T cell stimulation through CD3 and the CD28 co 
receptor. In a related study, we have recently found that phosphorylation of Zap-70, a key 
proximal effector kinase involved in early T cell signal transduction is significantly reduced in 
GPAT-1 (GPAM, human homologue) deficient Jurkat T cells, possibly indicating a defect in 
transmission of the stimulatory signal. GPAT-1 KO T cells have a dysfunctional phenotype 
similar to old cells characterized by decreased GPL to cholesterol ratios, decreased IL-2 
production, and a pro-inflammatory polarization of T cell subsets 
7
,
105
. In addition GPAT-1 KO 
mice are more susceptible to coxsackievirus B3 infection, suggesting that the in vivo adaptive 
immune response is indeed impacted by ex vivo dysfunction 
8
.  The data presented here show 
that T cells deficient in GPAT-1 have a blunted metabolic profile and reduced SRC compared to 
their WT counterparts. In addition, these defects only become apparent when the T cell is 
stimulated suggesting that GPAT-1 is necessary to meet increased energy demand placed on the 
cell following stimulation. In light of our previously reported finding that GPAT-1 activity is 
reduced in old rats 
9
, it is possible that T cell dysfunction associated with aging can be at least 
partly attributed to an inherent loss of GPAT-1 activity. Thusly, modulation of GPAT-1 activity 
may emerge as a principle target in the treatment of T cell dysfunction as we grow old. It will be 
interesting in the future to see how GPAT-1 KO T cells compare to old T cells in regard to their 
metabolic profile.  
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Figure 3.1 Mitochondrial Mass Determination with Mitotracker Staining 
 
 
Figure 3.1. Freshly isolated WT and GPAT-1 KO T cells were stained with 100 nM mitotracker 
red and fluorescence was analyzed by flow cytometry. Values respresent the mean +/- SEM of 
five individual mice. * Significantly different (p<0.05). 
 
b) 
a) 
c) 
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Figure 3.2 BrdU Proliferation Assay 
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Figure 3.2. T cells were isolated and pooled from 10 WT and 10 GPAT-1 KO mice and cultured 
in the presence of BrdU for 20 hours. Cells were then stained with antibodies directed against 
BrdU or CD4. Fluorescence was analyzed by flow cytometry.  
 
 
 
 
 
 
a) b) 
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Figure 3.3 Respiratory Profile with Inhibitor Treatment 
 
 
Figure 3.3. CD4
+
 T cells were isolated from age matched WT or GPAT-1 KO mice and 
stimulated or not in culture with CD3/CD28 antibody in complete medium. Cells were harvested 
and plated onto poly-l lysine coated dishes and basal oxygen consumption rate was analyzed 
followed by time specific injection of oligomycin, FCCP, and rotenone. Each point represents 
the mean +/- the SEM of five individual mice in triplicate on the plate. 
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Figure 3.4 Respiratory Response to Inhibitors and Spare Respiratory Capacity 
 
 
 
Figure 3.4. a). Basal OCR. b). Coupled, following oligomycin treatment. c). Uncoupled 
following FCCP Treatment. d). Spare respiratory capacity, calculated by subtracing uncoupled 
from basal OCR. e). Non-mitochondrial metabolism following rotenone treatment. f). Basal 
OCR/ECAR. Each bar represents the mean +/- SEM of five individual mice, in triplicate (for 
inhibitor addittion) or sextuplet (for basal readings),, and averaged across three time points. 
Significance is indicated by differing letters (p>0.05). Bars with same letters are not significantly 
different from each other. Significance was determined using one-way ANOVA and post-hoc 
analysis carried out with Tukey’s multi-comparison test (P>0.05). 
a) b) c) 
d) f) e) 
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Figure 3.5 Glycolytic Profile with Inhibitor Treatment 
 
 
 
 Figure 3.5. Glycolytic metabolic profile (ECAR). a) CD4
+
 T cells were isolated from age 
matched WT or GPAT-1 KO mice and stimulated or not in culture with CD3/CD28 antibody in 
complete medium. Cells were harvested and plated onto poly-l lysine coated dishes and basal 
oxygen consumption rate was analyzed followed by time specific injection of oligomycin, FCCP, 
and rotenone. Each point represents the mean +/- the SEM of five individual mice in triplicate on 
the plate. 
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Figure 3.6 Glycolytic Response to Inhibitors 
 
 
 
 
Figure 3.6. a).  Basal. b). Coupled, following oligomycin treatment. c). Uncoupled following 
FCCP Treatment. d). Following rotenone treatment. Each bar represents the mean +/- SEM of 
five individual mice, in triplicate (for inhibitor addition) or sextuplet (for basal readings), and 
averaged across three time points. Significance is indicated by differing letters (p>0.05). Bars 
with same letters are not significantly different from each other. Significance was determined 
using one-way ANOVA and post-hoc analysis carried out with Tukey’s multi-comparison test 
(P>0.05). 
a) b) 
d) c) 
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Figure 3.7 Fatty Acid Oxidation Respiratory Profile I 
 
 
Figure 3.7. CD4
+
 T cells were isolated from age matched WT or GPAT-1 KO mice and 
stimulated or not in culture with CD3/CD28 antibody in complete medium. Cells were harvested, 
transferred to KHB assay specific media and plated onto poly-l lysine coated dishes and basal 
oxygen consumption rate was analyzed followed by injection of 100 μM FA(palmitic acid)/BSA 
conjugate. Each point represents the mean +/- the SEM of five individual mice in triplicate on 
the plate. 
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Figure 3.8 Fatty Acid Oxidation Metabolic Profile II 
 
  
Figure 3.8. a). Basal OCR (average of 3 time points preceding injection). b). Basal ECAR 
(average of 3 time points preceding injection). c). OCR for FA injected (average of 10 time 
points following injection). d). ECAR for FA injected (average of 6 time points following 
injection). e). OCR for FA injected compared to BSA only injected controls (average of 10 time 
points following injection). f). ECAR for FA injected compared to BSA only injected controls 
(average of 6 time points following injection) Each bar represents the mean +/- SEM of five 
individual mice, in quintuplet (for basal readings) or triplicate (for FA injected) or duplicate (for 
BSA only injected), and averaged across multiple time points as indicated above. Significance is 
indicated by differing letters (p>0.05). Bars with same letters are not significantly different from 
a) b) c) 
d) e) f) 
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each other. Significance was determined using one-way ANOVA and post-hoc analysis carried 
out with Tukey’s multi-comparison test (P>0.05). 
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Chapter 4 
Discussion 
 T cells are principle effectors of the adaptive immune system and as such, are able to 
determine the type and extent of an immune response. Aging and more recently alterations in 
cellular metabolism have been demonstrated to significantly alter the subset polarization and 
functionality of the T cell compartment. Changes in T cell subset proportions or functionality can 
have profound effects on the adaptive immune response. Alterations in membrane 
glycerophospholipid levels are thought to be a major underlying cause of T cell dysfunction with 
aging. It is therefore important to understand how changes in lipid metabolism can alter T cell 
function.  
 The goal of this project was to identify mechanisms that contribute to the dysfunctional 
phenotype of GPAT-1 
-/-
 T cells. The first objective was to determine how and to what extent T 
cell metabolism is altered in the absence of GPAT-1. Recent studies have suggested that changes 
in the metabolic profile of T cells are responsible for defining specific effector functions and T 
cell subsets. So we asked the question as to whether our previous observations regarding T cell 
dysfunction in GPAT-1 
-/-
 T cells could possibly be explained by changes in the T cell response 
to stimulation or fatty acid addition.  Our experiments revealed several key metabolic defects in 
GPAT-1 
-/-
 T cells. First, we observed a significant reduction in mitochondrial mass in GPAT-1 
-
/-
 T cells compared to their WT counterparts indicating that GPAT-1 deficiency results in either 
fewer or smaller mitochondria. We have previously reported that proliferation is significantly 
reduced in GPAT-1 
-/-
 T cells as determined by MTT assay, however only at the specific time 
point of 20 hours. MTT reduction is actually an indicator of mitochondrial redox capacity, so in 
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light of our observations concerning mitochondrial mass we hypothesized that our previous 
results for the MTT assay were more indicative of mitochondrial dysfunction as opposed to 
proliferation. Therefore, we measured proliferation by a more direct means via BrdU 
incorporation assay. Consequently, we found decreased BrdU incorporation in GPAT-1 
-/-
 T cells 
although these differences were much smaller than those reported for MTT assay. Next we 
sought to characterize the metabolic profile of WT and CD4
+
 T cells. To accomplish this, we 
monitored the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR)  of 
WT and GPAT-1 
-/-
 T cells in order to precisely identify metabolic inconsistencies concomitant 
with GPAT-1 deficiency. We identified striking decreases in both the OCR and ECAR of GPAT-
1 
-/-
 T cells indicating an inherent cellular defect in energy production. These differences were 
observed throughout a series of mitochondrial stress tests using oligomycin, FCCP, and rotenone 
to detect OCR under coupled, uncoupled and non-mitochondrial respiration respectively. 
Treatment with FCCP and subsequent subtraction from basal readings allowed us to calculate the 
spare respiratory capacity (SRC) of GPAT-1 
-/-
 T cells, a key indicator of the cells ability to cope 
with mitochondrial stress. We found that the proportional decreases in the metabolic profile 
observed basally and in the presence of inhibitors were underscored by an inherent mitochondrial 
defect as evidenced by significantly decreased SRC in in GPAT-1 
-/-
 T cells. There also appeared 
to be no compensatory up regulation of glycolysis as measured by ECAR suggesting that GPAT-
1 
-/-
 T cells suffer from an energy sink which they may be unable to overcome. Intriguingly, we 
observed no significant difference in OCR or ECAR between WT and GPAT-1 
-/-
 T cells in the 
absence of stimulation strongly implying that GPAT-1 is absolutely critical for the cell to mount 
a proper metabolic response to the increased work load and stress associated with stimulation. 
We have previously reported increased CPT-1a protein expression in GPAT-1 
-/-
 thymocytes, so 
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we hypothesized that lipid oxidative modes of energy production may be skewed in CD4
+ 
GPAT-1 
-/-
 T cells. Addition of fatty acid (palmitate/BSA conjugate) and intermittent monitoring 
of OCR and ECAR in WT and GPAT-1 
-/-
 T cells actually revealed similar results to those 
observed in the respiratory assay with GPAT-1 
-/-
 T cells having consistently reduced metabolic 
profiles. However, one interesting difference was that stimulated GPAT-1 
-/-
 T cells responded to 
fatty acid addition in a similar manner to unstimulated WT cells. We also observed no 
compensatory increase in glycolytic modes of energy production as evidenced by decreased 
ECAR readings in GPAT-1 
-/-
 T cells compared to their WT counterparts. Another interesting 
finding from this study was that addition of fatty acid significantly increased OCR in all samples 
tested compared to BSA injected controls. That OCR was significantly increased in unstimulated 
samples suggests that fatty acid itself is capable of upregulating the metabolism in quiescent T 
cells. This is to the best of our knowledge a completely novel finding in regard to general T cell 
metabolic responses and may have far reaching implications in regard to the current paradigm. 
Taken together these results indicate that GPAT-1 is essential for regulation of the stimulation 
induced metabolic switch in T cells. Furthermore, this data indicates that GPAT-1 
-/-
 T cells have 
an inherent mitochondrial defect. These results are significant in regards to the field for three 
main reasons. First, we show here for the first time that deletion of a lipid biosynthetic protein 
has deleterious effects on total cellular metabolism under conditions of increased energy need. 
Second, altered metabolism in response to stimulation may be the defining mechanism 
underlying T cell dysfunction in GPAT-1 
-/-
 T cells and furthermore, in light of the similarities 
between GPAT-1 
-/-
 T cells and old T cells, loss of GPAT-1 activity with age likely leads to a 
similar phenotype in old T cells. Thusly, modulation of GPAT-1 activity may emerge as a 
principle target in the treatment of T cell dysfunction as we grow old. Lastly, we for the first time 
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link GPAT-1, an integral mitochondrial membrane protein to an inherent mitochondrial defect. 
This is important as the pleiotropic effects of reduced GPL have made it difficult to identify 
potential mechanisms related to GPAT-1 deficient T cell dysfunction.  
 The second objective of this project was to generate and characterize a cell line deficient 
in GPAT-1. We used an shRNA knock down (KD) strategy to target GPAM (human GPAT-1 
homologue) in Jurkat T cells with the goal being to generate a stable cell line deficient in GPAM. 
We achieved a 7.3 fold and 2.8 fold decrease in GPAM mRNA and protein respectively and 
were able to maintain this stable KD line (referred to throughout as GPAMKD Jurkat T cells) in 
culture. To the best of our knowledge, this is the first time that the GPAM has been targeted in a 
cell line of human lineage. We first asked the question as to whether GPAM KD had any effect 
on cellular proliferation similar to what we observed in primary murine GPAT-1 
-/-
 T cells. 
Interestingly, proliferation appeared unaltered in GPAMKD Jurkat T cells compared to 
scrambled shRNA transduced Jurkat T cells (ScshRNA Jurkat T cells). We next sought to 
determine whether apoptosis was elevated in GPAM KD Jurkat T cells compared to ScshRNA 
controls and intriguingly found significantly elevated levels of apoptosis in both stimulated and 
unstimulated GPAM KD Jurkat T cells. This observation implies that GPAMKD Jurkat T cells 
may actually proliferate at a higher rate than ScshRNA controls in light of the observed increases 
in cell death without apparent changes in proliferation. We have previously reported that IL-2, a 
key cytokine involved in T cell survival and proliferation is significantly reduced in GPAT-1 
-/-
 T 
cells, so we sought to determine whether the same was true in GPAMKD Jurkat T cells. We 
found a striking decrease in CD3/CD28 stimulation induced IL-2 production in GPAMKD Jurkat 
T cells at 24 hours equating to a 9 fold decrease in IL-2 production. However, an important 
question arises concerning measuring IL-2 production at 24 hours regarding whether the 
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cytokine is being secreted and subsequently taken back up by the cell. To address this question, 
we looked at IL-2 secretion at the peak production time point of 6 hours and saw nearly identical 
reductions (approximately 9 fold) as those observed at 24 hours. We next sought to further 
characterize the phenotype of GPAMKD Jurkat T cells by determining whether there were 
alterations in membrane GPL similar to those in the murine GPAT-1 
-/-
 T cells. Interestingly, we 
found significant decreases in phosphatidic acid (PA) and sphingomyelin (SM). These 
phospholipids play critical roles in the cell. Specifically, PA serves as the precursor to all GPL 
and also plays a critical role in mitogenic signaling serving as the docking site for Raf-1. We 
have previously reported significant decreases in PA in murine GPAT-1 
-/-
 T cells. Interestingly 
though, many of the other key phospholipids (PC, PE, PS) seemed to narrowly miss significance. 
It is highly likely that increased sample size and further analysis may reveal significant decreases 
in these phospholipids as well, similar to the murine GPAT-1 
-/-
 T cells. Another interesting 
finding was that SM, a key component of lipid rafts was significantly decreased in GPAMKD 
Jurkat T cells, but was actually the only major phospholipid not significantly decreased in 
murine GPAT-1 
-/-
 T cells. These findings are rather intriguing, as it presents the possibility that 
murine GPAT-1 and human GPAM differentially regulate phospholipid metabolism. Another 
possibility is related to the fact that Jurkat T cells are a human lymphoma cell line which has 
likely accumulated numerous mutations as immortal cancer cells. It is therefore likely that Jurkat 
T cells have compensatory mechanisms by which to compensate for GPL sinks not present in 
murine GPAT-1 
-/-
 T cells, such as up regulation of GPAT-3 or GPAT-4. It is also possible that 
Jurkat T cells have a second mitochondrial GPAM isoform (GPAT-2) capable of compensating 
for loss of GPAM. However, it is intriguing none the less that we see such profound effects on 
IL-2 production and cell death. Since PA is a precursor to all major membrane phospholipids we 
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hypothesized that supplementing GPAMKD T cells with PA may rescue their dysfunctional 
phenotype. We generated lipid micelles of two type of PA:  dioleoyl (18:1) and dilauroyl (12:0) 
PA. We then added the resulting micelles back to cultures of GPAMKD T cells and assessed IL-
2 secretion under various conditions and time points. We found that in no case was PA 
supplementation able to rescue the IL-2 deficient phenotype in GPAMKD T cells. One 
possibility is that the PA delivered was not entering the cell in a useable form or was quickly 
metabolized through other processes prior to reaching its target for either signaling or as a 
precursor to other phospholipids. Another possibility is that at the time points looked added PA 
there was inadequate time for sufficient lipid turnover in membranes to correct the defects 
associated with GPAM deficiency. It may also be that GPAM serves to regulate other processes 
such as modulating lipid metabolism by shunting fatty acyl CoA away from β-oxidation that are 
not corrected through PA addition. 
Next, we sought to link reduced IL-2 secretion to a cellular mechanism. Since IL-2 
production is directly regulated through signaling originating from the CD3 and CD28 co 
receptor we hypothesized that GPAM deficiency may be interfering with membrane based 
signaling. Certain components of the functional T cell signaling complex such as the CD28 co 
receptor exist on lipid rafts which translocate to the immunological synapse following 
stimulation. It is interesting then, that we observed decreases in sphingomyelin a principle lipid 
raft component suggesting that raft associated receptors such as CD28 may not be able to co 
localize to the TCR/CD3 complex. We therefore hypothesized that IL-2 production may be 
decreased due to loss of the co stimulatory CD28 signal. To test this hypothesis, we stimulated 
GPAMKD Jurkat T cells with CD3 or CD28 alone and subsequently measured IL-2 secretion. 
We subsequently found that IL-2 production was unaltered with CD3 stimulation alone, 
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suggesting that CD28 activation is dysfunctional in GPAMKD Jurkat T cells. However, the 
levels of CD3 only induced IL-2 production dwarf those of CD3/CD28 stimulation. We next 
hypothesized that if a membrane based defect exists in GPAMKD Jurkat T cells that prevents 
sufficient activation of signaling downstream of CD3 and CD28, then bypassing membrane 
based signaling should rescue IL-2 secretion. To test this, we stimulated GPAMKD and 
ScshRNA Jurkat T cells with PMA/Ionomycin, two compounds capable of inducing IL-2 
production in T cells through their ability to increase intracellular calcium levels and activate 
protein kinase C s (PKCs). The Jurkat T cell response to PMA/Ionomycin is well characterized 
with regards to their stimulatory effect on IL-2 production. We subsequently found that 
PMA/Ionomycin increased IL-2 secretion in ScshRNA controls approximately 4 fold and 
approximately 20 fold in GPAMKD Jurkat T cells compared to CD3/CD28 stimulation. This 
finding suggests that bypassing membrane based signaling partially rescues IL-2 production in 
GPAMKD Jurkat T cells. This data serves to further support our postulation that GPAM/GPAT-
1 deficiency results in perturbance of membrane based signaling as a consequence of altered 
membrane phospholipid ratios. To further investigate the possibility that GPAM deficiency 
results in dysfunctional TCR/CD3/CD28 induced signaling we sought to determine whether Zap-
70 phosporylation was decreased in GPAMKD Jurkat T cells. Zap-70 is a key effector kinase 
activated very early (within seconds) following T cell stimulation. Zap-70 plays a critical role in 
propagating the TCR/CD3/CD28 stimulatory signal. We found that following stimulation, Zap-
70 phosphorylation is significantly reduced in GPAMKD Jurkat T cells compared to ScshRNA 
controls suggesting that the dysfunctional T cell phenotype observed in GPAMKD Jurkat T cells 
is likely due to inadequate activation of the TCR/CD3/CD28 complex. These findings are highly 
significant for three main reasons. First, we show here for the first time that Jurkat T cells 
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deficient in GPAM have many of the same dysfunctional T cell characteristics as primary murine 
GPAT-1 
-/- 
T cells. That many aspects of the phenotype are recapitulated in a human cell line 
strongly suggests that GPAM serves a conserved function in mammalian T cells. The importance 
of GPAM in T cell function is highlighted by the fact that such a profound phenotype was 
observed in a T cell lymphoma cell line. Second, we show that GPAM/GPAT-1 deficiency is a 
cell inherent defect. The GPAT-1 
-/-
 mouse is a whole animal GPAT-1 knock-out. As such, 
certain questions arise regarding the origin of the dysfunctional T cell phenotype and specifically 
to what extent developmental or peripheral processes influence the phenotype. Since we 
recapitulated nearly all key aspects of the dysfunctional phenotype in GPAMKD Jurkat T cells, it 
is highly probable that GPAT-1/GPAM deficiency results in a cell inherent defect in T cell 
functionality. Lastly, we demonstrate that T cell dysfunction in GPAM deficient Jurkat T cells 
can at least in part, be attributed to a defect in membrane based signaling. This finding supports 
our metabolic work in GPAT-1 
-/-
 T cells where we show they are unable to upregulate their 
metabolism to meet the increased energy needs associated with stimulation.  
 These data pose a number of important questions that future experiments should be 
designed to address. First, the results from our studies investigating the metabolic profile of 
GPAT-1 
-/- 
T cells identified a profound metabolic defect in response to stimulation and 
decreased mitochondrial mass. However, the precise mitochondrial status and health of GPAT-1 
-/- 
T cells remains unknown. Future experiments should examine indicators of mitochondrial 
health including redox and mitochondrial outer membrane potential. Work from the lab of 
Rosalind Coleman revealed that GPAT-1 
-/- 
hepatocytes suffer from a mitochondrial defect 
related to increased susceptibility to opening of the mitochondrial permeability transition pore 
(MPTP) 
14
. The MPTP is a protein pore formed in the inner mitochondrial membrane in response 
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to stress that can result in mitochondrial swelling and apoptosis. Elevated intracellular Ca2
+
 is 
capable of inducing MPTP opening. It is therefore important that one of the principle events 
following T cell stimulation is a rise in intracellular Ca2
+
, so then, it follows to question whether 
stimulation induces opening of the MPTP in GPAT-1 
-/- 
T cells. It is possible that altered 
phospholipid composition in cellular membranes has profound effects on mitochondrial 
membranes that influence both mitochondrial membrane potential and permeability. MPTP 
opening and subsequent loss of mitochondrial outer membrane potential (MOMP) could be a key 
contributing factor in the reduced metabolic profile we observe in GPAT-1 
-/- 
T cells. 
Specifically, the finding that spare respiratory capacity (SRC) is significantly decreased in 
GPAT-1 
-/- 
T cells is highly suggestive of an integral mitochondrial defect in the cellular 
response to stress or increased work load as brought on by stimulation. Interestingly, old T cells 
have also been shown to undergo enhanced activation of the MPTP 
110
 . Furthermore, aging has 
also been associated with decreased SRC in a variety of cell types which may contribute to their 
inability to deal with increased cellular stress such as ROS, which is also consequently elevated 
with age 
108
. Future experiments should examine stimulation induced opening of the MPTP and 
monitor loss of MOMP. Furthermore, experiments should be designed to more closely examine 
the metabolic profile of old T cells. These data in combination with the results of the current 
studies would solidify a role for GPAT-1 in maintaining mitochondrial health and stability not 
previously described and further strengthen our hypothesis that loss of GPAT-1 activity with age 
is a principle contributor to T cell dysfunction and that consequently the GPAT-1 
-/- 
mouse is an 
ideal model to study the aged T cell phenotype in a young mouse.  
 Second, GPAMKD Jurkat T cells recapitulate many of the key aspects of the GPAT-1 
-/- 
T cell phenotype including reduced IL-2 production, and altered membrane phospholipid mass. 
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The GPAMKD Jurkat T cell line is an ideal model to study mechanisms by which changes in 
phospholipid mass concomitant with loss of GPAM/GPAT-1 cause T cell dysfunction. Our 
results suggest that GPAMKD T cells suffer from a defect in TCR/CD3/CD28 activation and 
subsequent downstream signal transduction possibly as a result of membrane perturbances that 
prevent or interfere with aggregation of lipid raft localized receptors such as CD28. Future 
experiments should be designed to more closely examine formation of a functional immune 
synapse in GPAMKD Jurkat T cells. This can be accomplished using the Raji B cell lymphoma 
line loaded with SEE superantigen. Superantigens are capable of non-specific T cell activation 
resulting in subsequent stimulation and cytokine production. Raji B cells loaded with SEE 
superantigen are capable of stimulating Jurkat T cells in culture and forming cell-cell 
immunological synapses. Labeling of CD3, CD4, and CD28 with fluorescently conjugated 
antibodies followed by fluorescent confocal microscopy could reveal whether GPAMKD Jurkat 
T cells are forming a proper immunological synapse. Fluorescence resonance energy transfer 
(FRET) could also be used to specifically determine whether CD28 is co localizing to the 
immunological synapse following stimulation. FRET works by two chromophores interacting 
when they are in close enough proximity which induces a shift in the fluorescence wavelength 
that can subsequently be quantified. These experiments would provide insight as to whether 
alterations in phospholipid mass observed in GPAMKD Jurkat T cells prevent adequate co 
receptor aggregation at the immunological synapse. Failure to form a functional immune synapse 
could explain nearly all characteristics of the dysfunctional T cell phenotype we have described 
in both GPAMKD Jurkat T cells and primary murine GPAT-1 
-/-
 T cells. If a defect is indeed 
present in GPAMKD Jurkat T cells the next step would be to replicate these experiments in 
primary GPAT-1 
-/- 
T cells. One possible way to accomplish this task would be to cross GPAT-1 
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-/-
 mice with commercially available TCR transgenic mice expressing a αβ TCR specific for a 
defined peptide of a commonly used antigen such as influenza hemaglutinin (HA) or ovalbumin 
(OVA) capable of presentation by MHC class II. Several rounds of inbreeding should yield 
transgenic mice GPAT-1 
-/- 
/TCR 
specific 
mice. Murine antigen presenting cells (APC) could then 
be pre-loaded with TCR specific peptide and experiments carried out as described for GPAMKD 
Jurkat T cells.  
 Lastly, GPAT-1 
-/-
 T cells share many dysfunctional characteristics with old T cells. 
These observations in combination with our previous data showing that GPAT-1 activity is 
reduced in T cells from old rats presents the intriguing possibility that T cell dysfunction with 
age can be at least partially attributed to loss of GPAT-1 activity and alterations in membrane 
phospholipid mass. The first step in exploring this possibility in more detail would be to 
determine whether GPAT-1 reconstitution is capable of rescuing the dysfunctional phenotype of 
GPAT-1 
-/- 
T cells. This experiment could be accomplished by first isolating primary murine 
GPAT-1 
-/-
 T cells and transducing them with a lentivirus capable of delivering a functional 
GPAT-1 gene under the control of a strong murine promoter in addition to a reporter gene such 
as GFP. Transduce GPAT-1 
-/-
 T cells could be cultured for a sufficient period of time to allow 
for expression of GPAT-1 and GFP and then subsequently sorted by FACS on GFP. The 
experiments to follow would include: phospholipid mass analysis, cytokine analysis, 
proliferation, and metabolic profile. This proof of principle experiment would form the 
foundation for further studies aimed at determining whether GPAT-1 is capable of rescuing the 
dysfunctional phenotype of old T cells. An important point to make concerning these 
experiments is that T cells from old rats have reduced levels of GPAT-1 activity while protein 
expression is unaltered 
9
. Therefore, it appears that aging reduces activation-dependent 
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mitochondrial GPAT-1 activity. Further studies by our group in Rat T cells revealed that GPAT-
1 activity is positively regulated through phosphorylation by casein kinase 2 (CK2) and, protein 
kinase C theta (PKC-θ), which plays a critical role during T cell activation 27. CK2 has also been 
shown to activate rat michondrial GPAT-1 activity 
114
. Studies aimed at determining whether 
GPAT-1 can rescue T cell dysfunction with aging should therefore be focused on modes of 
enhancing GPAT-1 activity. CK2 is capable of phosphorylating a wide variety of cellular targets 
in many tissues, so future experiments in T cells should focus on enhancing PKC-θ mediated 
phosphorylation of GPAT-1. However, a confounding “which came first” problem surfaces 
when considering PKC-θ mediated phosphorylation of GPAT-1. If GPAT-1 activity is 
contingent upon adequate stimulatory signal leading to PKC-θ activation and this stimulatory 
signal is dependent on GPAT-1 to provide a proper phospholipid ratios in the membrane to 
provide this signal, how does the T cell reach this point and what should be targeted first? Initial 
experiments should be designed to determine whether indirect activation of PKC-θ is capable of 
improving the phenotype in old T cells. It is very important to point out here that the dysfunction 
in GPAT-1 
-/-
 T cells is much less present or not at all when T cells are stimulated with 
PMA/Ionomycin which can directly activate PKCs bypassing membrane dependent signals. This 
is a critically important observation and strongly suggests that T cell dysfunction in the absence 
of GPAT-1 is modulated through defects in membrane based signaling. Early studies 
investigating the effects of PMA/Ionomycin in the aged T cell response reported that IL-2 
supplementation in addition to PMA/Ionomycin treatment is capable of fully restoring the aged T 
cell response to that of young T cells 
115
. This provides a foundation that allows for more direct 
probing of the role of GPAT-1, since it has been shown that bypassing membrane based 
signaling and providing IL-2 is already capable of rescuing the aged T cell dysfunction. Future 
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experiments should therefore be directly aimed at enhancing GPAT-1 activity in old T cells. One 
possible way to carry out these experiments would be to transfect old primary T cells with a 
constitutively active GPAT-1 followed by pheonotypic characterization. These experiments 
could potentially identify GPAT-1 as a critical effector of immunosenescene and thereby provide 
a target to improve immune function with aging, or possibly slow or even stop age associated T 
cell mediated immune dysfunction.  
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